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1Drug-related deaths in 
Ireland, 2004–2013
The latest figures from the National Drug-Related Deaths Index (NDRDI) show that a total of 679 deaths in Ireland during 2013 were linked to drug use. These figures are contained in a recent NDRDI report which 
provides information on deaths from poisoning, trauma or medical causes in 
which drugs were a factor in the fatality during the period 2004–2013.1 
Speaking at the launch of NDRDI’s latest web update on 15 December 2015, Minister 
of State for Drugs, Aodhán Ó Ríordáin, expressed his concern about the rising number 
of deaths, the increase in heroin deaths and, in particular, heroin deaths linked 
to injecting. He said the government has taken steps to prevent these deaths by 
expanding needle exchange services and making naloxone for the treatment of opiate 
overdose more widely available.
Some of the key findings of the report are:
 ■  Alcohol was implicated in 1 in 3 (137) of all poisoning deaths in 2013, and alcohol 
poisoning alone claimed one life each week. 
 ■ 234 people (60%) died in 2013 because they took a mixture of drugs. 
 ■  Heroin deaths increased in 2013 for the first time since 2009. In 2013, 86 poisoning 
deaths (one in five) were heroin-related and in almost 50% of these deaths, the user 
was injecting at the time. 
1  Health Research Board (2015) Drug-related deaths and deaths among drug users in Ireland: 
2013 figures from the National Drug-Related Deaths Index. Dublin: Health Research Board. 
www.drugsandalcohol.ie/24676 
Issue 56 
Winter 2016
The newsletter of Ireland’s focal point to the EMCDDA
drugnet 
IrElAnD
To have Drugnet Ireland  
delivered to your desktop,  
sign up on the NDC website
www.drugsandalcohol.ie
Alcohol diary 
interactive tables
See page 10
Improving people’s health through research and information
Minister of State for Drugs, Aodhán Ó Ríordáin, Ms Ena Lyn, author, Dr Graham Love, CEO, 
HRB and Dr Suzi Lyons author at the launch of the Drug-related deaths in Ireland,  
2004–2013 report in December.
 > Regulating sponsorship
 > Minimum unit pricing
 > Politicians and drug 
policy reform
 > Health behaviour in 
school-aged children
 > Communities and 
alcohol-related harm 
prevention
 > Inspector of Prisons 
report
2drugnet 
Ireland
The NDRDI reports on poisoning deaths (also known as 
overdoses), where the drug, or combination of drugs, 
actually poisoned the person, and on non-poisonings, 
which are deaths as a result of trauma (such as hanging) or 
medical reasons (such as cardiac events) among people who 
use drugs. The latest figures on both poisoning and non-
poisoning deaths are presented in Table 1.
Poisoning deaths in 2013
The annual number of poisoning deaths increased from 
361 in 2012 to 387 in 2013. As in all previous years, males 
accounted for the majority of deaths (68% in 2013). The 
median age was 41 years.
Almost two thirds (60%) of all poisoning deaths involved 
more than one drug (polydrug use):
 ■  Alcohol was involved in 35 per cent of poisoning deaths 
in 2013, making it the drug most commonly involved in 
poisoning deaths. Alcohol alone was responsible for 15 
per cent of all deaths.
 ■  Methadone was implicated in a quarter of poisonings in 
2013. The majority of deaths (94%) in which methadone 
was implicated were polydrug poisonings. 
Drug-related deaths (continued)
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Table 1 Number of poisoning and non-poisoning deaths, by year, NDRDI 2004–2013 (N=6,002)
 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
All deaths 432 505 554 622 628 658 609 657 658 679
Poisonings (3,519) 267 300 325 389 386 374 342 388 361 387
Non-poisonings (2,483) 165 205 229 233 242 284 267 269 297 292 
Minister of State for Drugs, Aodhán Ó Ríordáin at the  
launch of the Drug-related deaths in Ireland, 2004–2013  
report in December.
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Two fifths (41%) of poisonings in 2013 involved 
benzodiazepines, almost all (99%) of which involved 
polydrug use.
The number of poisoning deaths in which heroin was 
implicated increased for the first time since 2009, being a 
factor in 22 per cent of poisoning deaths in 2013:
 ■  Over two-fifths (42%) of people for whom heroin 
(injecting or smoking) was implicated in their death were 
not alone at the time they took the drug.
 ■  Half (49%) of those who died from a heroin-related death 
were known to be injecting at the time of their death.
 ■  Three in five (62%) of deaths in 2013, where heroin was 
injected, occurred in a private dwelling.
Over two fifths (43%) of those who died of a poisoning 
death in 2013 had a history of mental health illness.
The number of deaths involving antidepressants and other 
prescription drugs has increased. Citalopram is the most 
common antidepressant implicated in these deaths, being 
implicated in over one fifth (22, 22.4%) of individual deaths 
involving antidepressants in 2013. 
Non-poisoning deaths in 2013
The number of non-poisoning deaths recorded among drug 
users decreased slightly, from 295 in 2012 to 292 in 2013 
(Figure 1). In 2013, males accounted for 77 per cent of all 
non-poisoning deaths. Almost two fifths (38%) of those who 
died of non-poisoning had a history of mental illness.
 
Deaths owing to hanging continue to be the main cause 
of non-poisoning deaths, accounting for 25 per cent of all 
non-poisoning deaths in 2013 (Figure 2). In 2013, almost 
two thirds (59%) of deaths owing to hanging were among 
people who had a history of mental health illness. 
The most common medical causes of death were cardiac 
events, accounting for 18 per cent of all non-poisoning 
deaths in 2013 (Figure 2).
The data show that a younger cohort died from traumatic 
causes (median age 34 years) in comparison to medical 
causes (median age 47 years).
(Ena Lynn)
Drug-related deaths (continued)
Figure 1: Non-poisoning deaths among drug users, NDRDI 2004–2013 (N=2,398)
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Figure 2: Non-poisoning deaths among drug users, by main type of death, NDRDI 2004–2013 (N=1,748)
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Public Health (Alcohol) Bill 2015
Minister for Health Leo Varadkar launched the Public Health 
(Alcohol) Bill on 8 December 2015.1 The Bill addresses 
alcohol as a public health issue for the first time and it aims 
to reduce alcohol consumption in Ireland to 9.1 litres of 
pure alcohol per person per annum by 2020 and to reduce 
alcohol-related harm. 
Main provisions of the Bill
The main provisions of the Bill include minimum unit 
pricing, health labelling of alcohol products, the regulation 
of advertising and sponsorship of alcohol products, structural 
separation of alcohol products in mixed trading outlets, and 
the regulation of the sale and supply of alcohol in certain 
circumstances.
  
Minimum unit pricing
Minimum unit pricing will tackle the sale of cheap alcohol 
particularly in the off-trade sector and the price will be 
set at 10 cent per gramme of alcohol. This means that a 
750ml bottle of wine with an ABV (alcohol by volume, 
alc/vol) of 12.5 per cent cannot be sold for less than 
€7.50. This is aimed at those who drink in a harmful 
and hazardous manner and its effects will be felt most 
keenly by high-risk drinkers. Research by the University of 
Sheffield has estimated that this measure alone could save 
€1.7 billion over 20 years by reducing healthcare costs, 
crime and policing, reducing absenteeism, and improving 
quality of life.2 
  
Health labelling     
Compulsory health labelling will mean that alcohol 
containers are required to carry information about the 
amount of alcohol measure in grammes and the calorie 
count; health warnings, including one for pregnancy; and 
a link to a public health website (to be set up by the HSE). 
On- and off-licences will be required to display a notice 
with health warnings indicating that grammes and calorie 
content for ‘poured drinks’ can be found in a document 
available upon request.
Alcohol advertisements
The Bill restricts alcohol advertisements so that they can only 
give specific information about the product. This will mean 
that advertisements will be less likely to glamourise alcohol 
or make it appealing to children. The Bill bans advertising 
near schools, early years services, playgrounds and public 
transport. Alcohol-related advertisements will be restricted 
to films with an ’18 and over’ certificate and there will be a 
9.00 pm broadcasting watershed for alcohol advertisements. 
Advertising will be prohibited in sports grounds for events 
where the majority of competitors or participants are children, 
and merchandising of children’s clothing is also restricted. 
Structural separation
Structural separation in mixed trading outlets means that 
alcohol must be stored either in a separate area of the 
shop through which customers do not have to pass to buy 
‘ordinary’ products, or in a closed storage unit(s) which 
contains only alcohol products. Alcohol products behind 
check-out points will need to be concealed.
Promotions
Promotions whereby alcohol products are sold at a reduced 
price or free of charge will be restricted or banned; these 
include promotions targeted to a particular category of 
persons, and ‘happy hour’ type promotions.
Enforcement and review
The provisions in the Bill will be enforced by authorised officers 
of the HSE. The provisions will be reviewed after three years 
from commencement to examine their effectiveness. 
(Deirdre Mongan)
1  Public Health (Alcohol) Bill 2015, Bill Number 120 of 2015. 
Retrieved 21 December 2015 http://www.oireachtas.ie/
viewdoc.asp?DocID=30442&&CatID=59 
2  Angus C, Meng Y, Ally A, Holmes J and Brennan A (2014) 
Model-based appraisal of minimum unit pricing for alcohol in the 
Republic of Ireland. Sheffield: ScHARR, University of Sheffield. 
http://www.drugsandalcohol.ie/23904/ 
Regulating sponsorship by alcohol 
companies of major sporting events
In 2013 the Irish government established a working group to 
examine the regulation of sponsorship by alcohol companies 
of major sporting events. The working group reported its 
findings in December 2014.1 
Comprised of representatives from several government 
departments, the working group was asked to ‘consider 
the value, evidence, feasibility and implications (including 
the public health consequences for children and young 
people and the financial impact on sporting organisations) 
of regulating sponsorship by alcohol companies of major 
sporting events’ and ‘to consider alternative sources of 
funding for sporting organisations to replace potential lost 
revenue arising from any such regulation’. Following an initial 
analysis of the relevant available information and identifying 
information gaps, the group formulated a set of questions 
with a view to gathering evidence to facilitate a complete 
understanding of the issue. These questions were sent to key 
stakeholders. Main findings of the group were as follows.
Impact of sports sponsorship on alcohol 
consumption 
Sports sponsorship is usually part of an integrated marketing 
approach, making it difficult to untangle the specific impacts 
each marketing activity has and to draw conclusions about 
the potential impact of restrictions on alcohol sponsorship of 
sports events. It is generally accepted that the share prices 
of companies react positively to sports sponsorship, while 
customers operate on the principle that if a brand is good 
enough to back a much-loved sport, then it’s good enough 
for them. 
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There is high-quality international evidence demonstrating  
a link between general marketing and alcohol consumption.  
A systematic review of 13 longitudinal studies of 38,000 
young people aged 10–21 years concluded that ‘alcohol 
marketing increases the likelihood that adolescents will start 
to use alcohol and to drink more if they are already using 
alcohol’.2 The alcohol industry disputes the link between 
marketing and increased consumption, claiming that 
marketing simply acts as a brand differentiator. 
The evidence with regard to links between sports sponsorship 
and alcohol consumption is limited. Research from Australia 
and New Zealand has shown that sportspeople receiving 
alcohol industry sponsorship at a team or club level are 
more likely to be hazardous drinkers. The working group 
acknowledges that there is a lack of Irish research measuring 
the impact of sports sponsorship by alcohol companies, and 
it is not clear to what extent social norms or accepted cultural 
behaviour in Irish society influence drinking behaviour, 
compared to the alcohol industry.
Given the lack of evidence with regard to impact, the 
working group looked at what other countries had done 
regarding alcohol sponsorship of sport. In France the Loi 
Evin has imposed a complete ban on alcohol sponsorship of 
sporting events. This law made it impossible for American 
brewer Anheuser-Busch to sponsor the 1998 FIFA Football 
World Cup in France despite heavy lobbying of the French 
government. There has been a 20 per cent decline in alcohol 
consumption in France since the law came into effect in 
1990 but this downward trend began in the 1960s. It is not 
clear how much of the decrease can be attributed to the Loi 
Evin as opposed to other factors. 
Value of alcohol sponsorship to  
sporting organisations 
A 2011 report for the Drinks Industry Group of Ireland 
estimated that the value of sports sponsorship was €35 
million; this was regarded as a conservative figure.3 The 
value of alcohol sponsorship is largely invested in the GAA 
(Gaelic Athletic Association), FAI (Football Association of 
Ireland) and IRFU (Irish Rugby Football Union). The major 
sporting organisations which presented submissions to the 
working group stated that the loss of the funding through 
sports sponsorship would have a detrimental impact on 
local clubs and on their capacity to offer development 
programmes for young people. The FAI and the IRFU 
expressed concerns that additional restrictions could 
jeopardise their chances of participating in international 
tournaments. There were alternative views that restrictions 
might not harm sporting organisations; it was noted that the 
Loi Evin had not prevented France from hosting both soccer 
and rugby World Cups. 
Alternative sources of sponsorship for the  
sports sector
Conflicting views were given regarding alternative sources of 
sponsorship. While some submissions claimed that alcohol 
sponsorship could be gradually replaced by revenue from 
other commercial companies, it was also stated that even 
if alternative sponsors could be found, these organisations 
would be unlikely to pay the premium price that alcohol 
sponsors do, which would lead to a decrease in  
sponsorship revenue. 
The experience of the GAA in securing sponsorship 
unrelated to alcohol companies was cited as an example 
that alternative sponsors can be found. The Australian 
government’s willingness to replace alcohol sponsorship 
with state funding was also mentioned: it had committed 
to providing A$25 million over four years for a ‘community 
sponsorship fund’ as an alternative for sporting and cultural 
organisations. The working group concluded it was not 
possible to answer this question, but noted that if the 
current economic recovery continues, other commercial 
sources of revenue might become available.
Options for regulation which fall short of a ban 
The report examines the features of successful regulatory 
schemes, namely volume restrictions, content restrictions 
and an effective system of regulation. 
 ■  Imposing volume restrictions on alcohol marketing 
can be successful if the proposed bans are not merely 
symbolic but contribute substantially to the total volume 
of alcohol advertising to which adolescents are exposed, 
and if no significant substitution effects arise such as 
price reductions or marketing shifts to other media. 
 ■  Limiting exposure to attractive advertisements by 
adjusting their content can be an important restriction. 
In France advertisements can only contain product 
information, such as the name of the product, 
percentage alcohol by volume, origin, name and address 
of manufacturer, and consumption mode of the product. 
 ■  Regulation needs a clear legislative framework. Effective 
regulation requires pre-screening of advertisements, 
a complaints system, effective sanctions, and an 
independent monitoring system that routinely monitors 
the content and volume of alcohol marketing.
Conclusions
The working group could not reach clear evidence-based 
conclusions on the actual costs and benefits of further 
regulation of alcohol sponsorship of sporting events. It 
concluded that the most useful approach would be to 
identify a number of options ranging from maintaining 
the status quo to banning sponsorship of major sporting 
events by alcohol companies, and seek to elaborate the likely 
advantages and disadvantages of each approach, to inform 
the government’s consideration of the matter. 
(Deirdre Mongan)
1  Department of the Taoiseach (2014) Report of the working 
group on regulating sponsorship by alcohol companies of major 
sporting events. http://www.taoiseach.gov.ie/eng/Work_Of_
The_Department/Social_Policy_and_Public_Service_Reform/
Report_of_the_Working_Group_on_Regulating_Sponsorship_
by_Alcohol_Companies_of_Major_Sporting_Events.pdf 
2  European Health and Alcohol Forum (2009) Does marketing 
communication impact on the volume and patterns of 
consumption of alcoholic beverages, especially by young people? 
– a review of longitudinal studies. http://ec.europa.eu/health/
ph_determinants/life_style/alcohol/Forum/docs/science_o01_
en.pdf 
3  Foley A (2011) The contribution of the drinks industry to tourism, 
festivals and sport. Drinks Industry Group of Ireland.  
http://www.drugsandalcohol.ie/15823/
Regulating alcohol sponsorship (continued)
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Adolescents’ exposure to alcohol 
marketing 
Alcohol Action Ireland commissioned the Health Promotion 
Research Centre at NUI Galway to undertake research on  
the extent and nature of Irish adolescents’ exposure to 
alcohol marketing and to determine the relationship 
between exposure to alcohol marketing and alcohol  
drinking behaviour.1 
The study population consisted of 686 secondary school 
children aged 13 to 17 years (52.6% boys, 47.4% girls), from 
16 schools in counties Galway, Dublin and Cork. Between 
April and May 2013 students were asked to complete a 
questionnaire on their opinions, health behaviours, family, 
leisure activities, and exposure to alcohol marketing, and to 
complete an alcohol marketing diary to record all alcohol 
marketing they encountered during one week day and one 
weekend day. They were asked to note the alcohol brand 
being advertised, the media channel through which it was 
presented, where and when it was seen or heard, and how 
appealing the advertisement was to them.
Results
Almost two thirds of the students reported that they 
consumed alcohol (boys 62.5%, girls 65.4%). This was more 
common among 16–17-year-olds (74.6%) than among 
13–15-year-olds (53.5%). Among those who drank, 23.6 per 
cent of 13–15-year-olds and 51.4 per cent of 16–17-year-
olds reported being drunk in the past month.
Girls were more likely than boys to report online exposure to 
alcohol advertising (Table 1). A number of different types of 
online exposure were measured. In the previous week 72 per 
cent saw an online advert/pop-up for an alcohol product, 
15.4 per cent received an online quiz about alcohol or 
drinking, 35 per cent were invited to ‘like’ an alcohol brand, 
29.7 per cent were invited to ‘like’ an event sponsored by an 
alcohol brand, and 21.4 per cent were invited to go to an 
event sponsored by an alcohol brand. Younger children were 
as exposed as older children to alcohol advertisements. Boys 
were more likely to report that the last sports event they 
attended was sponsored by an alcohol brand and to own 
alcohol-branded merchandise. Children reported to have 
seen a mean of 7.4 alcohol advertisements in the week prior 
to the survey (boys 8.2, girls 6.5). Those aged 13–15 years 
reported seeing more advertisements than 16–17-year-olds 
(7.6 vs 7.2). Overall, 56 per cent of children reported seeing 
more than four advertisements on a weekday and 54 per 
cent reported seeing more than four advertisements on a 
weekend day. 
Logistic regression analysis showed that increased exposure 
to alcohol marketing increased the risk of children engaging 
in the drinking behaviours examined (drinking alcohol, 
binge drinking, drunkenness, intention to drink in the next 
year), compared to children who were not exposed to 
alcohol marketing. In general, the higher the number of 
exposures (alcohol advertisements), the more common the 
drinking behaviours became. Owning merchandise, which 
may be described as engagement with alcohol brands 
beyond passive exposure, was the strongest predictor of 
alcohol behaviours.
Conclusions
It is clear that Irish children are exposed to large volumes 
of alcohol marketing, which increases their likelihood of 
drinking alcohol and engaging in risky drinking behavior, 
which is consistent with results from research conducted 
internationally. Given young people’s vulnerability to 
alcohol-related harm, there is a definite need for immediate 
and effective action on alcohol marketing regulation. These 
results indicate that the current Irish regulatory system fails 
to protect children from exposure to alcohol marketing. 
The proposed Public Health (Alcohol) Bill 2015 is an 
important first step in this regard as alcohol marketing will 
be regulated by way of a statutory code rather than the 
existing system of self-regulation. There will be restrictions 
on advertising of alcohol on television and radio, in 
cinemas and via outdoor media. However, the bill includes 
no provisions dealing with online marketing, which is an 
important element of the alcohol marketing mix in Ireland 
and needs to be regulated. 
(Deirdre Mongan)
1  Fox K, Kelly C and Molcho M (2015) Alcohol marketing and 
young people’s drinking behaviour in Ireland. Galway: National 
University of Ireland Galway. http://www.drugsandalcohol.
ie/24854/
Table 1: Percentage of students reporting exposure to various types of alcohol marketing, 2013
Online 
exposure
Non-online 
exposure
Alcohol branded 
merchandise 
ownership
Last sports event 
attended was sponsored 
by an alcohol brand
Last music event 
attended was sponsored 
by an alcohol brand
All students 77.2 90.9 61.2 18.3 16.1
Boys 74.0 90.5 71.4 22.8 15.4
Girls 80.8 91.3 50.0 13.2 16.9
13–15-year-olds 74.9 90.7 63.9 18.6 14.6
16–17-year-olds 79.6 91.0 58.5 18.0 17.6
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Preventing alcohol-related harm:  
what communities can do 
In February 2013 Galway Healthy Cities Alcohol Forum 
launched its strategy to prevent and reduce alcohol-related 
harm in Galway City between 2013 and 2017.1 The Forum 
includes representatives from HSE West, the Western Drugs 
and Alcohol Task Force, Galway–Roscommon Education and 
Training Board, An Garda Síochána, Galway City Council, 
Galway City Public Participatory Network and National 
University of Ireland Galway. 
Under the Prevention ‘pillar’ in the strategy, and in pursuit of 
the strategic action – to ‘communicate effective measures to 
prevent and reduce alcohol-related harm and the benefits of 
undertaking these measures’ – the Forum recently published 
a booklet presenting the scientific evidence for various alcohol 
policies in order of effectiveness, and suggesting actions the 
community can undertake in relation to each policy.2
1. Supply 
Supply policies include reducing affordability, availability and 
marketing. Increasing the price of alcohol reduces alcohol 
consumption and alcohol-related harm. The main alcohol 
pricing policies are alcohol taxation and minimum unit 
pricing. Policies to reduce availability include limiting the 
number of outlets licensed to sell alcohol, limiting the hours 
of sale, setting a minimum purchase age, preventing sales to 
intoxicated people, and limiting drinking in public places. To 
reduce children’s exposure to marketing and resultant harm, 
statutory regulation is needed with a monitoring system that 
is totally independent, clear to all, accountable and involves 
young people.
Community action opportunities 
 ■  Advocate for minimum pricing policy as a matter of 
urgency.
 ■  Examine the potential to reduce very cheap discounts, 
through voluntary agreements with alcohol sellers, while 
waiting for the Public Health (Alcohol) Bill 2015 to be 
enacted.
 ■  Map the number, type and density of outlets selling 
alcohol in the community.
 ■  Increase enforcement of alcohol laws through a systems 
approach regarding youth access, distance sales, 
secondary purchasing, serving intoxicated customers and 
drink–driving.
 ■ Limit drinking in public places through local bye-laws.
 ■  Examine current licensing laws and propose changes to 
benefit the community’s safety.
2. Early intervention and treatment
There is a strong body of high-quality evidence showing that 
effective intervention by the health sector can prevent and 
reduce alcohol-related harm. Brief alcohol interventions are 
particularly effective among hazardous and harmful drinkers 
who are not seeking treatment. Psychosocial counselling 
for treatment-seeking patients has the strongest evidence 
of effectiveness and can be supported by pharmacological 
interventions. The precise combination of treatment 
depends on the severity of the problem, the goals of 
treatment, and the patient’s preferences.
Community action opportunities
 ■  Provide training, support and incentives for alcohol 
screening and brief advice in primary care, emergency 
care, general hospitals and third-level colleges.
 ■  Identify and develop local pathways for treatment service 
at the individual and family level.
 ■  Ensure a broad base of treatment options and evidence-
based interventions are available within the community.
 ■  Ensure the local community are aware of how to access 
alcohol treatment services and are encouraged to do so.
3. Prevention and awareness
Prevention policies tend to focus on information, education 
and persuasion programmes. While information and 
education are important for the public to understand the risks 
associated with drinking, prevention policies have little value 
in reducing alcohol-related harm if implemented alone.
Community action opportunities
 ■  Increase the awareness of the range of alcohol-related 
problems in the community.
 ■  Promote the benefits of reducing alcohol-related problems 
– improved community safety and better quality of life.
 ■  Increase the understanding of the large evidence base of 
what works and what does not work in reducing alcohol-
related harm.
 ■  Ensure the local community understand that protecting 
children is everyone’s responsibility and how best to 
achieve this.
4. Monitoring and evaluation
It is important that a community action plan has clear 
outcome measures against which success can be monitored. 
A monitoring system should be put in place at the outset to 
track progress.
Community action opportunities
 ■  Undertake a community audit; identify needs and 
priorities for the community.
 ■  Build awareness within the community so that everyone 
has a role to play.
 ■ Put a monitoring system in place.
 ■  When planning to deliver evidence-based interventions, 
ensure independent evaluation takes place to build the 
knowledge base in Ireland. 
 ■  Ensure the community alcohol action group, 
representing the collective process, has regular 
roundtable discussions with all relevant sectors in the 
community to review progress and plan future actions.
(Deirdre Mongan)
1  Galway City strategy to prevent and reduce alcohol-related harm 
2013–2017. http://www.drugsandalcohol.ie/19344/ 
2  Hope A (2015) Research evidence to prevent alcohol-related 
harm: what communities can do in Ireland. Galway Healthy 
Cities: Galway City Alcohol Strategy to Prevent and  
Reduce Alcohol-Related Harm (2013-2017).  
http://www.drugsandalcohol.ie/24166/
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Minimum unit pricing for alcohol:  
what will it really mean?
The publication of the HRB’s National Alcohol Diary report 
reinforced the case to introduce minimum unit pricing 
(MUP) for alcohol in Ireland.1 The recent response of the 
European Court of Justice’s Advocate General re-ignited the 
debate and was taken by some to suggest that MUP was not 
going to be legally enforceable. However, the judgement 
was a little bit more nuanced than that.2 
What the European Court of Justice’s Advocate General 
actually said was that MUP for alcohol is legal ‘on condition 
that it shows that the measure chosen presents additional 
advantages or fewer disadvantages by comparison with the 
alternative measure’, in this case, general taxation. 
There is compelling international evidence that pricing 
is one of the most effective ways to reduce alcohol 
consumption and tackle alcohol-related harm. The World 
Health Organization (WHO) has made it clear that there is 
‘indisputable evidence that the price of alcohol matters’:3 if 
the price of alcohol goes up, alcohol consumption and its 
related harm goes down. An increase in the price of alcohol 
through taxation is a general pricing intervention that will 
reduce alcohol consumption among all drinkers equally and 
decrease its related harms. 
However, MUP is a targeted measure, designed to reduce 
alcohol consumption among heavy drinkers and harmful 
drinkers (such as binge drinkers). Cheap alcohol products 
are favoured by the heaviest drinkers, who generally seek 
to get as much alcohol as they can for as little money as 
possible and are most at risk of alcohol-related illnesses and 
death. In addition, young people, who generally have the 
least disposable income but the highest prevalence of binge 
drinking, buy cheap alcohol. An MUP policy stops alcohol 
being sold at very low prices in the off-trade, particularly 
supermarkets, where alcohol is frequently used as a ‘loss 
leader’ and sold below cost. 
MUP is a ‘floor price’, beneath which alcohol cannot legally 
be sold, and is based on the amount of alcohol in a product, 
measured in grammes. One standard drink in Ireland 
contains 10 grammes of alcohol and an MUP would apply 
per standard drink. Under an MUP policy of one euro per 
standard drink, 
 ■ a bottle of spirits could not be sold for less than €21, 
 ■ a bottle of wine could not be sold for less than €7, and
 ■ a pint of beer could not be sold for less than €2.
The evidence for the benefits of MUP can already be seen 
in Canada. For example, in British Columbia a 10 per cent 
increase in the MUP was associated with a 32 per cent fall  
in wholly alcohol-related deaths, while it also led to 
reductions in alcohol-related hospital admissions and crime, 
particularly alcohol-related traffic offences and crimes against 
the person.4 
In 2013 the Sheffield Alcohol Research Group (SARG) 
adapted the Sheffield pricing model for alcohol to Ireland 
in order to appraise the potential impact of different pricing 
policies.5 In the following example from this appraisal, MUP 
is compared to general taxation. 
 ■  For a €1 MUP policy, the estimated per-drinker-reduction 
in alcohol consumption for the overall population is 
estimated at 8.8 per cent and equated to an average 
annual reduction of 57.2 standard drinks per drinker per 
year. As this is a targeted pricing policy, high-risk drinkers 
have larger estimated reductions in alcohol consumption 
as a result of an MUP policy than increasing-risk or low-
risk drinkers. For example, the estimated reductions in 
consumption for a €1 MUP are 15.1 per cent for high-
risk drinkers, 7.2 per cent for increasing-risk drinkers and 
3.1 per cent for low-risk drinkers. 
 ■  The introduction of a 10 per cent (tax) increase on the 
price of all types of alcohol (cheap and expensive) would 
decrease alcohol consumption for all drinkers by 5–6 per 
cent and would affect low-risk, increasing-risk and high-
risk drinkers equally. 
The Scottish Court of Session has already considered this 
matter and is of the view that taxation is ‘likely to be 
less effective in achieving the legitimate aims which the 
minimum pricing measures pursue’.6 Ireland’s MUP model 
also demonstrates that MUP has additional advantages over 
a 10 per cent general tax increase on alcohol. 
(Jean Long and Brian Cummins)
1  Long J and Mongan D (2014) Alcohol consumption in Ireland 
2013: analysis of a national alcohol diary survey. Dublin: Health 
Research Board. http://www.drugsandalcohol.ie/22138/
2  The Scotch Whisky Association and Others v The Lord 
Advocate and The Advocate General for Scotland 2015. 
http://curia.europa.eu/juris/document/document.
jsf?text=&docid=166846&pageIndex=0&doclang=en&mode= 
req&dir=&occ=first&part=1&cid=210514
3  World Health Organization Europe (2009) Evidence for the 
effectiveness and cost-effectiveness of interventions to reduce 
alcohol-related harm. http://www.euro.who.int/__data/assets/
pdf_file/0020/43319/E92823.pdf 
4  Stockwell T and Thomas G (2013) Is alcohol too cheap in the 
UK? The case for setting a Minimum Unit Price for alcohol. An 
Institute of Alcohol Studies report. http://www.ias.org.uk/
uploads/pdf/News%20stories/iasreport-thomas-stockwell-
april2013.pdf 
5  Angus C, Meng Y, Ally A, Holmes J and Brennan A (2014) 
Model-based appraisal of minimum unit pricing for alcohol in the 
Republic of Ireland. Sheffield: ScHARR, University of Sheffield. 
http://www.drugsandalcohol.ie/23904/
6  Petition for judicial review by Scotch Whisky Association & 
others http://www.scotland-judiciary.org.uk/9/1040/Petition-
for-Judicial-Review-by-Scotch-Whisky-Association-And-Others 
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Alcohol conference and training seminar
The North Dublin Regional Drugs and Alcohol Task Force 
(North Dublin RDATF) held a two-day alcohol event on 8–9 
October 2015.1 The first day consisted of a conference on 
the topic ‘Alcohol through the ages: from the cradle to the 
grave’. It was open to all service providers working with 
people affected by alcohol. Speakers included the following:
 ■  Dr Adam Winstock, consultant addiction psychiatrist  
and Director of the Global Drug Survey, gave the 
keynote address. 
 ■  Dr Suzi Lyons, Health Research Board, set the national 
context using routine surveillance data.
 ■  Dr Gerry McCarney from SASSY – Substance Abuse 
Service Specific to Youth – spoke about alcohol 
treatment challenges in emergency medicine, and 
adolescents and alcohol use. 
 ■  Aoife Dermody along with Marie Lawless presented the 
first results from the evaluation of the CARE (Community 
Alcohol Response and Engagement) community-based 
intervention, an initiative of the Ballymun Local DATF, 
which was rolled out in partnership with the North 
Dublin RDATF and the Fingal/Cabra LDATF.2 (See 
separate report on the evaluation of CARE on pp. 20--21 
later in this issue.) 
 ■  Megan O’Leary from the National Family Support 
Network presented on the impact of alcohol on the 
family and carers.
 ■  Monica Hynds and Robert Dunne from Barnados 
discussed parental alcohol use and the impact  
on children.
 ■  Dr Winstock discussed physical complications from 
alcohol, diagnosing dependence and brief screening  
and interventions. 
The second day comprised clinical training for treatment 
providers and GPs, delivered by the indefatigable Dr Adam 
Winstock. Topics covered included alcohol assessment, 
monitoring and management of alcohol withdrawal, and 
maintaining abstinence with pharmacotherapies. Eighty 
professionals attended this training.
 
The main ‘learnings’ from the two days are summarised 
below.
 ■  More robust local data on alcohol consumption and 
help-seeking behaviours are required. Compiling 
data from easily accessible digital health applications, 
for example the ‘Drinks meter’,3 which incorporates 
screening and brief intervention tools (including Audit C) 
and has the potential to gather information on a  
large number of people within the task force area,  
could provide meaningful data in relation to alcohol 
use and assist with the planning of services. The North 
Dublin RDATF is planning to use this app across a 
number of services. 
 ■  There is value in community-based outpatient alcohol 
treatment approaches incorporating both medical and 
psychosocial interventions. 
 ■  Alcohol needs to be more strongly emphasised in the 
new National Drugs Strategy due to be adopted in 2016. 
Although nationally there is acceptance that marketing, 
availability and supply are key issues in relation to 
tackling alcohol problems, there is very little emphasis on 
treatment despite the level of need.
 ■  Screening and early alcohol interventions need to be 
provided in order to improve outcomes for service users 
and to reduce the negative impacts on individuals, 
families and the wider community. Many primary care 
providers, i.e. GPs and pharmacists, are well placed to 
work alongside community-based services to deliver 
these interventions but they need appropriate training 
and resources to do so. 
 ■  The National Drugs Rehabilitation Framework4 needs 
to be updated to include alcohol in a more meaningful 
way. The HSE and national treatment policies continue to 
focus mainly on opiates. 
 ■  Feedback from clinicians indicates that they feel they 
are not getting enough training and development 
opportunities for alcohol treatment, particularly as the 
emphasis is often on opiate treatment. 
 ■  Greater integration is needed between medical 
professionals, mental health specialists and project/case 
workers in community-based psychosocial services.
 ■  A minority of service users need alcohol detoxification, 
and many of these could be safely managed in the 
community if adequate medical, pharmacological and 
social support were available. 
 ■  The impact of problematic alcohol use on families (i.e. 
children, adults, parents and service users) should be 
factored into any strategic planning for alcohol.
 ■  A more targeted focus on prevention and assessment  
for foetal alcohol syndrome is needed. This should  
be specifically outlined in the forthcoming National 
Drugs Strategy. 
(Suzi Lyons and Bríd Walsh)
1 For more information see http://www.ndublinrdtf.ie/
2  See Dermody, A and Banka P (2015) Evaluation of CARE 
(Community Alcohol Response and Engagement) pilot project: 
Ballymun, Finglas and North Dublin. Dublin: Ballymun Local 
Drugs & Alcohol Task Force /Quality Matters. http://www.
drugsandalcohol.ie/24700/ 
3 See http://drinksmeter.com/
4  See http://www.drugsandalcohol.ie/13502/1/National_Drugs_
Rehabilitation_Framework_2010.pdf
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National Alcohol Diary Survey data:  
new interactive tables 
 
As part of our ongoing work in making data relating to drug 
and alcohol use available to those who wish to research this 
topic, the HRB National Drugs Library recently published 
interactive tables on data gathered through the 2013 
National Alcohol Diary Survey.1 This survey estimated the 
personal consumption of, and expenditure on, alcohol 
among the general population aged 18–75 years living 
in private households in Ireland. The survey included a 
comprehensive series of questions on both the rates and 
patterns of alcohol consumption and on alcohol-related 
harm, and involved interviewing 5,991 respondents in  
3,897 households. 
The respondents were randomly selected using a two-stage 
probability sampling procedure. The survey was completed 
between July and October 2013, and achieved a household 
response rate of 67.2 per cent and a within-household 
response rate of 77.1 per cent. The survey population was 
weighted by age, gender and regional distribution, to ensure 
that it mirrored the Central Statistics Office’s population 
estimates for 2013.
The new interactive tables will enable you to search the 
survey data for information relating to the:
 ■ age at which respondent started drinking alcohol;
 ■  number of respondents who consumed alcohol in the  
12 months prior to the survey and in the week prior  
to the survey;
 ■  number of standard drinks respondents consumed on a 
typical drinking occasion;
 ■ amount of money the respondents spent on alcohol;
 ■  number of standard drinks typically consumed on a 
drinking occasion; and 
 ■  harms that have resulted from the respondent’s own 
drinking or as a result of other people’s drinking. 
Use the interactive tables at http://www.drugsandalcohol.ie/
national-alcohol-diary-survey/
1  Long J and Mongan D (2014) Alcohol consumption in Ireland 
2013: analysis of a national alcohol diary survey. Dublin: Health 
Research Board. http://www.drugsandalcohol.ie/22138/
Politicians call for drug policy reforms
In November 2015 a number of high-profile Irish politicians 
called for a variety of reforms in drug policy including 
medically-supervised injecting facilities; decriminalisation 
of drug use; the adoption of compassion, human rights 
and equality, community and democratic participation as 
appropriate platforms on which to think about the drugs 
problem; and the adoption of a health rather than a criminal 
justice approach to the drugs problem. Whether this month 
will be remembered as a turning point will depend on 
whether and how the debate is taken forward by political 
parties in the run-up to the 2016 general election, and 
whether and how the debate is reflected in Ireland’s third 
national drugs strategy, due by the end of 2016.1 
Minister of State with responsibility for the 
Drugs Strategy
On 2 November Minister Aodhán Ó Ríordáin gave the keynote 
address at a meeting of the London School of Economics 
IDEAS International Drug Policy Project.2 He outlined his views 
in favour of two new harm-reduction options.
Medically-supervised injecting facilities
‘Addiction is not a choice, it’s a healthcare issue. This is why 
I believe it is imperative that we approach our drug problem 
in a more compassionate and sensitive way. One of the key 
things that I aim to achieve during my remaining time in 
office is the introduction of a medically supervised injecting 
centre for intravenous drug users. … I have asked officials in 
my Department to examine proposals for the provision of 
medically supervised injecting facilities as a response to this 
issue. This is in line with similar models in Sydney and parts of 
Europe. … as the recent spike in blood-borne viruses in Dublin 
was among those who are most likely to avail of supervised 
injecting facilities, I hope that the introduction of these facilities 
may reduce the risk of future spikes occurring.’
Decriminalisation
‘Since taking up my new role as Minister for Drugs, I have 
spoken to a lot of people who would like to see a more 
compassionate approach to those who experience drug 
problems. Too often those with drug problems suffer 
from stigma, due to a lack of understanding or public 
HRB National Drugs Library 
The HRB launched its strategy for 2016–20 and rebranding 
on 19 January. As part of the HRB’s new strategy the 
National Documentation Centre on Drug Use has changed 
its named to HRB National Drugs Library. Our new name 
and new look website was introduced on the same day as 
the HRB strategy. 
We will continue to develop our online resources and 
evidence services during 2016 and we’ll have details  
of our plans for the coming years in the next issue of 
Drugnet Ireland. 
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education about the nature of addiction. This stigma can be 
compounded for those who end up with a criminal record 
due to possession of drugs for their own use.
‘It is against this background that there is now an emerging 
debate in Ireland on whether an alternative approach to the 
possession of small quantities of illicit drugs for personal use 
should be considered.
‘I am in favour of a decriminalisation model, but it must be 
one that suits the Irish context and it must be evidence-
based. I believe that this kind of approach will only work  
if it is accompanied by timely treatment and harm reduction 
services, backed up by wrap-around supports which  
foster recovery – such as housing, health and social  
care. Above all, the model must be person-centred 
and involve an integrated approach to treatment and 
rehabilitation based on a continuum of care with clearly 
defined referral pathways.’
Joint Committee on Justice, Defence  
and Equality
On 5 November the Joint Committee on Justice, Defence and 
Equality of the Oireachtas (Houses of Parliament) released a 
report recommending ‘a harm-reducing and rehabilitative 
approach to possession of small amounts of illegal drugs’.3 
Following a visit by a delegation representing the Committee 
to Portugal in mid-2015 and further investigation and 
deliberation at home, the Committee concluded that there 
is merit in further exploring the Portuguese model and in 
examining how it may be adapted for use in an Irish context. 
The Committee suggested that a health/counselling/ 
treatment approach might be more effective and more 
appropriate for those found in possession of a small amount of 
illegal drugs for personal use rather than imposing a criminal 
sanction resulting in a lifelong criminal record. 
Specific recommendations
The Committee:
1.  strongly recommended the introduction of a harm-
reducing and rehabilitative approach, whereby the 
possession of a small amount of illegal drugs for personal 
use, could be dealt with by way of a civil/administrative 
response and rather than via the criminal justice route;
2.  recommended that discretion for the application of  
this approach should remain with An Garda Síochána/
health providers;
3.  recommended that any harm-reducing and  
rehabilitation approach be applied on a case-by-case 
basis, with appropriately resourced services available  
to those affected;
4.  drew attention to the success of ‘informal’ interaction 
with users when referred to the ‘Dissuasion Committees’ 
in Portugal and recommended that such an approach 
should be employed in Ireland; 
5.  recommended that resources be invested in training and 
education on the effects of drugs and that appropriate 
treatment be made available to those who need to avail 
of same; and 
6.  recommended that research be undertaken to ensure 
that the adoption of any alternative approach be 
appropriate in an Irish context.
Committee on Justice, Defence and Equality – 
Membership
Member  Party
Deputies  
Niall Collins Fianna Fáil
Alan Farrell Fine Gael
Anne Ferris (Vice Chair) Labour
Seán Kenny Labour
Pádraig Mac Lochlainn Sinn Féin
Gabrielle McFadden Fine Gael
Finian McGrath Independent
Fergus O’Dowd Fine Gael
David Stanton (Chair) Fine Gael
Senators  
Ivana Bacik Labour
Martin Conway Fine Gael
Tony Mulcahy Fine Gael
Rónán Mullen Independent
Denis O’Donovan Fianna Fáil
Katherine Zappone Independent
The President of Ireland
On 12 November Michael D Higgins gave the opening 
address at CityWide’s 20th anniversary conference, held in 
Dublin, which was entitled ‘Our Communities, Our World 
– A Drugs Policy that Works’.4 While the President did not 
comment on drug policy, he did discuss the principles  
that he believes should underpin and inform public policy.  
A selection of his comments are reproduced below.
Equality and human rights 
‘A main theme of my Presidency has been to build an 
inclusive Republic – one in which all citizens are treated with 
equal dignity and respect and are empowered to participate 
in our democracy. As a society we have made progress in 
realising equality for many groups … If we are to achieve the 
goal of a true Republic and give expression to the vision of 
universal human rights, then we must seek out and embrace 
those of our fellow citizens who are most vulnerable and 
suffer the greatest exclusion. … drug users and those 
affected by addiction are often in that position of exclusion 
and denial of citizenship. They are often regarded as being 
outside or even below the community of rights-holders in 
our society. Their addiction – a medical and social condition 
which causes them suffering and impairment – is used as a 
basis to dehumanise drug users. That dehumanisation takes 
the form of stigmatisation and derogatory language; and 
it leads to a denial of services, a lack of voice, and even, on 
occasion, is used as a justification for victimisation.’
Communities
‘It is often to their community that addicts turn as they seek 
to reclaim their lost selves and become, once again, engaged 
citizens with a lifetime of possibility in front of them. For 
some time now the value of a community approach and 
active citizenship in supporting those struggling with 
addiction, and providing a base on which to build effective 
policy, has been widely recognised. 
Politicians call for reform (continued)
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There can be no doubt about the real merit in allowing 
individuals to engage and participate in the decisions which 
affect and shape their communities, and the critical role of 
communities in ensuring long term sustainable solutions to 
problems such as drug abuse within our society.’
Participative citizenship and democracy
 ‘As a country we owe a great debt to CityWide who, across 
the years have reached out to those who struggle to address 
addiction in their lives and to live creatively and realise 
their own unique path and endless possibilities. Your work 
continues to be vital as we work to craft a shared future in 
which all our citizens are treated with dignity, allowed a 
voice and a right to participate in society. … CityWide  
is a valuable and uplifting example of participative  
citizenship and democracy, reminding us of all that  
is best about Irish society.’ 
(Brigid Pike)
1  For an account of Dáil debates on the drugs issue over the past 
10 years, see Pike B (2014) Dáil debate on cannabis Drugnet 
Ireland (49): 6–8, http://www.drugsandalcohol.ie/21673/ ; 
Pike B (2012) Politicians and the drugs debate – six years on 
Drugnet Ireland (41): 10 www.drugsandalcohol.ie/17272/ ; 
and Pike B (2006) Politicians and the drugs debate Drugnet 
Ireland (19): 16–17 www.drugsandalcohol.ie/11285/ 
2  Address by Minister Aodhán Ó Ríordáin TD to the London 
School of Economics IDEAS Forum on 2 November 2015. 
http://www.drugsandalcohol.ie/24742/ 
3  Joint Committee on Justice, Defence and Equality (2015, 5 
November) Report of the Committee on a harm reducing and 
rehabilitative approach to possession of small amounts of illegal 
drugs http://www.drugsandalcohol.ie/24750/ 
4  Opening address at the CityWide 20th Anniversary 
Conference, Croke Park, Dublin, 12 November 2015. 
Retrieved on 16 November 2015 http://www.president.ie/en/
media-library/speeches/opening-address-of-the-citywide-20th-
anniversary-conference 
Politicians call for reform (continued)
Towards UNGASS 2016
Since Issue 48, Drugnet Ireland has carried ‘Towards  
UNGASS 2016’ as a regular column. It reports on policy 
initiatives, research and debates launched by the UN, member 
states and civil society organisations in the lead-up to the UN 
General Assembly Special Session (UNGASS) on the world drug 
problem, due to be held in New York on 19–21 April 2016. 
www.ungass2016.org
On 14 October 2015 the International Drug Policy 
Consortium (IDPC) held an informal briefing for member 
states at the UN headquarters in New York. It was entitled 
Preparing for UNGASS 2016: Examining complex drug policy 
issues. The briefing was co-sponsored by the United Nations 
and the Permanent Mission of Switzerland to the UN. In 
introducing the three contributors, the Swiss ambassador 
to the UN highlighted the need for drug policies to be 
based on human rights and public health principles and the 
importance of considering the full range of linkages between 
the world drug problem and Agenda 2030.1 
1.  Dr Renata Segura of the Conflict Prevention and 
Peace Forum of the Social Science Research Council 
highlighted the difficulty of finding common ground 
between the idealistic approach of minimising the 
availability of illicit drugs, as advocated by the UN’s 
drug-policy-making body, the Commission on Narcotic 
Drugs (CND), and the views of some member states 
and academic civil society, who question how realistic 
the aspiration of a drug-free world is. She challenged 
UNGASS 2016 to examine the impact that drug 
trafficking is having on society, and to analyse the 
consequences of the current drug control regime.
2.  Professor Jeffrey S. Fagan of the New York-based 
Columbia Law School discussed the proportionality 
of punishment in the context of drug-related offences, 
focusing in particular on whether or not capital 
punishment is an effective deterrent to drug use and 
trafficking. Citing empirical evidence obtained over a 
five-decade long study, he concluded that the research is 
clear that the use of the death penalty has no deterrent 
effect on serious crimes such as murder. 
3.  Dr Dan Werb of the Toronto-based International 
Centre for Science in Drug Policy highlighted the 
importance of recognising the inherent limitations of 
current drug policies in their overall effectiveness related 
to drug consumption patterns: his analysis of the drug 
policies of several locations (Vancouver, Switzerland 
and Mexico) suggested that both liberal and stringent 
approaches produce very similar results with regard 
to the age of onset and rate of use for cannabis and 
cocaine. Among other matters, he discussed the need 
to re-evaluate the current metrics used to evaluate the 
effectiveness of drug policies, and urged a broadening  
of metrics to include a range of indicators based  
on community health, security, human rights,  
and development.
Videos of the presentations by the three speakers are 
available on line at http://idpc.net/blog/2015/10/
preparing-for-ungass-2016-examining-complex-drug-
policy-issues?utm_source=IDPC+Monthly+Alert&utm_
campaign=d08071d8c0-IDPC+November+2015+Alert&utm_
medium=email&utm_term=0_d40f46a7df-
d08071d8c0-18215073 
In November 2015 United Nations University (UNU) 
published What comes after the war on drugs – flexibility, 
fragmentation or principled pluralism? UNU is a global think-
tank established by the UN General Assembly to contribute, 
through collaborative research, to helping resolve ‘pressing 
global challenges’. A series of meetings, attended by 
delegates from more than 50 UN member states and 
representatives of UN entities and civil society and academic 
organisations and aimed at ‘identifying common ground’, 
examined the relationship between contemporary global 
drug policy and public health, human rights, development 
and criminal justice. 
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Drawing on these consultations, the authors of the ‘policy 
report’, James Cockayne and Summer Walker, have discerned 
a clear trend heading into UNGASS 2016: member states will 
largely coalesce around an affirmation of the existing regime, 
coupled with a call for flexibility in implementing the regime. 
The USA and some Latin American countries have called 
for flexibility as a way to experiment with new approaches 
to implementing the existing drug control regime, but 
other states are likely to treat an agreement on flexibility 
as an acceptable response to their calls for respect for state 
sovereignty in setting domestic drug policy, including the 
use of strong punitive approaches. According to the authors, 
there is a consequent danger, post UNGASS 2016, that 
flexibility will lead to policy fragmentation. 
The authors argue that the key to avoiding fragmentation 
is to ensure that flexibility is not treated as a code word 
for unprincipled laissez faire, but instead is embedded in a 
process of collective drug policy development at the UN, 
based on a more detailed and holistic analysis by member 
states and other stakeholders of ‘what works’ in drug policy 
interventions. They argue that UNGASS 2016 should be seen 
not as the end of a conversation about drug policy, but as an 
opportunity to set up a structured and inclusive conversation 
between 2016 and 2019, when the current Political 
Declaration and Plan of Action comes to an end, and a new 
one will likely be adopted. They argue that UNGASS 2016 
should initiate a conversation that, though leaving room for 
states to exercise flexibility and discretion, ensures that their 
policy choices are guided by three principles: 
 ■ protection of human rights,
 ■ promotion of human development, and 
 ■ guidance by the best available scientific evidence. 
The authors describe this approach as principled pluralism.
http://i.unu.edu/media/unu.edu/news/72569/UNU_Drug_
Policy_Online_Final.pdf 
On 12 November 2015 CityWide Drugs Crisis Campaign 
held a conference in Dublin on drug policy reform, seeking 
to answer three questions:
1.  What have we learnt from 20 years’ experience of trying 
to tackle the drugs issue here in Ireland?
2.  How can we link our experience in Ireland to the 
international debate on moving from the ‘war on drugs’ 
to a public health and human rights approach?
3.  How can we bring together the learning and evidence 
from the Irish and the international experience to feed 
into the new Irish National Drugs Strategy?
Speakers in the morning included: 
 ■  President of Ireland, Michael D. Higgins (see separate 
report on pp. 11–12 above) 
 ■  Ann Fordham (Executive Director, International  
Drug Policy Consortium): The UN General Assembly 
Special Session on Drugs & the shifting global drug  
policy landscape
 ■  José Antonio Gutiérrez Danton (academic, researcher , 
community activist): International drugs policy and the 
‘War on Drugs’ – the impact on communities in Colombia 
 ■  John Collins (Co-ordinator, LSE IDEAS International Drug 
Policy Project): Linking current developments in Irish drugs 
policy to the international policy context
 ■  Niall O’Connell (Service User Rights in Action): 
Supporting a human rights approach to delivery of drug 
services 
 ■  Anna Quigley (Co-ordinator, Citywide Drugs  
Crisis Campaign): 20 years’ experience of community 
involvement – key lessons for the next National  
Drugs Strategy
In the afternoon conference participants broke out into 12 
workshops on the following topics:
 ■  Medically-supervised injecting centres – a case study in 
bringing about drug policy reform in Ireland 
 ■  Understanding and responding to drug-related 
community violence and intimidation 
 ■  Implementing decriminalisation – developing a model 
that works in Ireland 
 ■  Developing the unique role of community drug projects 
– the factors that make them effective in their work and 
the challenges they are facing 
 ■  The role of the media in the discussion of social policy – 
how to support a rational and informed public debate on 
drug policy reform 
 ■  Developing a human rights approach to delivery of  
drug services – A case study on the experience of 
methadone treatment 
 ■  Women and the National Drugs Strategy – the impact 
on women of current drug policy and what needs to be 
included in the next NDS 
 ■  Equality and diversity in the new NDS – how to ensure 
inclusion of Travellers, New Communities, LGBT and 
other minority groups 
 ■  The value of family support – how the value of family 
support work can be understood and measured 
 ■  The role of youth work in developing and supporting 
effective models of drugs education, prevention and 
harm reduction 
 ■  Developing an integrated approach to the issues of  
drug use and homelessness – the experience from  
the frontline 
 ■  What Ireland can contribute to UNGASS 2016 – 
examining the concepts of regulation and legalisation 
Videos of the speeches, and PowerPoint presentations made 
at workshops, are available on line at http://www.citywide.
ie/citywide-20th-anniversary/presentations.html 
(Compiled by Brigid Pike)
1  For more information on Agenda 2030, visit 
https://sustainabledevelopment.un.org/post2015/
transformingourworld 
Towards UNGASS 2016 (continued)
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First national youth strategy launched
On 8 October 2015 the Minister for Children and Youth 
Affairs, Dr James Reilly TD, launched the National youth 
strategy 2015–2020.1 Ireland’s first-ever youth strategy, it 
sets out the government’s aim and objectives for young 
people aged 10 to 24 years, so that they can be active 
and healthy, achieve their full potential in learning and 
development, be safe and protected from harm, have 
economic security and opportunity, and be connected and 
contribute to their world. The strategy focuses particularly 
on young people experiencing, or at risk of experiencing, 
the poorest outcomes.
The National Youth Strategy identifies some 50 actions to be 
delivered by government departments, state agencies and 
others, including voluntary youth services, between 2015 
and 2017. The actions include access to online youth mental 
health services, a national obesity policy and action plan, 
youth entrepreneurship initiatives in schools and youth work 
settings, and opportunities for young people furthest from 
the labour market. 
In launching the National Youth Strategy, the Minister 
announced a new Youth Employability Initiative. This 
€600,000 initiative will provide grants to voluntary youth 
services for programmes that target disadvantaged young 
people to improve their employability. The initiative will 
target young people who are most at risk of unemployment 
and who are not in education, employment or training and 
will provide programmes for them to enhance their skills.  
It is anticipated that up to 20–25 new youth projects and  
an estimated 200–300 young people could be assisted by 
this initiative. 
The wider context
The National Youth Strategy has been developed within the 
context of the Better outcomes, brighter futures: the national 
policy framework for children & young people 2014–2020, 
which is Ireland’s first national policy framework for children 
and young people aged 0–24 years.2 This policy framework 
captures all children and youth policy commitments across 
all government departments and agencies in relation to five 
outcome areas and six key transformational goals.3 
As well as the National Youth Strategy described above, two 
other strategies are being rolled out within the context of 
this over-arching policy framework:
 ■  The National strategy on children and young people’s 
participation in decision-making, 2015–2020, was 
published in June 2015.4 The action plan for 2015 
published with this strategy includes the following 
commitments (p. 48):
–  ‘Young people will be centrally involved in the 
development and management of drug and alcohol-
free venues and programmes for young people (e.g. 
youth cafés, alcohol-free music and dance venues, and 
sports venues), with an emphasis on those most at risk.
–  The Health Service Executive (HSE) will develop 
mechanisms, including consultation and feedback 
mechanisms, for the participation of service users, 
families and carers in the decision-making processes of 
mental health services for young people at local and 
national levels.
–  Children and young people will be consulted by 
services seeking to respond to parental substance 
misuse or substance misuse in families as targeted by 
the ‘Hidden Harm’ initiative.
–  Children and young people will be included in 
consultations with communities to inform the 
development of Primary Care Services.
 ■ The National early-years strategy has yet to be published.
(Brigid Pike)
1  Department of Children and Youth Affairs (2015) National 
youth strategy 2015–2020. Dublin: Government Publications. 
http://www.drugsandalcohol.ie/24606/
2  Department of Children and Youth Affairs (2014) Better 
outcomes, brighter futures: the national policy framework for 
children & young people (2014–2020) Dublin: Government 
Publications. http://www.drugsandalcohol.ie/21773/ 
3  For an overview of the outcomes and aims, see Keane 
M (2014) National policy framework for children and 
young people Drugnet Ireland (51): 5–6. http://www.
drugsandalcohol.ie/22906/ 
4  Department of Children and Youth Affairs (2015) National 
strategy on children and young people’s participation in decision-
making, 2015–2020 Dublin: Government Publications. http://
www.drugsandalcohol.ie/24612/
Health behaviour in school-aged 
children, 2014
The first Health Behaviour in School-Aged Children 
(HBSC) survey was conducted in Ireland in 1998 and has 
been repeated every four years since. In 2014 Ireland 
participated for the fifth time in the HBSC study. The 
survey included 13,611 school-children drawn from 3rd 
class in primary school through to 5th year in post-primary 
school; 230 primary and post-primary schools across 
Ireland participated. Data were collected on general health, 
smoking, use of alcohol and other substances, food and 
dietary behaviour, exercise and physical activity, self-care, 
injuries, bullying and sexual health behaviours. The main 
results were published in December 2015.1 
This article describes the results pertaining to the use of 
alcohol and other substances, which were reported in the 
main report, and makes comparisons with the previous 
HBSC surveys. It also includes a more in-depth analysis of 
alcohol and cannabis use, which was prepared by the HBSC 
at the Health Research Board’s request.2
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Alcohol
Overall, 51 per cent of 13–17-year-olds reported that they 
had ever had an alcoholic drink. Use of alcohol increased 
with each year of age and, with the exception of 17-year-
olds, boys were more likely than girls to have ever drunk an 
alcoholic drink (Figure 1). 
Almost one in five 13–17-year-olds (19.3%) reported 
that they had drunk alcohol in the last 30 days. A higher 
proportion of boys in all age groups (except for 17-year-
olds) reported drinking in the last 30 days, compared to girls 
(Table 1). 
Table 1: Percentage of 13–17-year-olds reporting having 
had an alcoholic drink in the past month, by age and 
gender, 2014
Age All Boys Girls
13 years 4.9 6.1 4.2
14 years 12.9 13.6 12.4
15 years 24.1 25.5 23.2
16 years 42.7 43.4 42.2
17 years 61.1 57.7 63.7
Over one-quarter of 13–17-year-olds (26.6%) reported  
that they had ever been ‘really drunk’. For each age, boys 
were more likely than girls to report lifetime drunkenness 
(Figure 2).
Cannabis
The majority of 13–17-year-olds (90.1%) reported that they 
had never used cannabis. Just under 10 per cent reported 
having used cannabis in the last 12 months. Cannabis use 
increased with each year of age and was more common 
among boys (Figure 3). There were no statistically significant 
social class differences. 
Overall, in 2014 one in twenty (5%) school-aged children 
reported using cannabis in the last 30 days (Table 2).
Table 2 Percentage of 13–17-year-olds reporting use of 
cannabis in the last 30 days, by age and gender, 2014
Age All Boys Girls
13 years 0.9 1.1 0.7
14 years 2.6 3.0 2.4
15 years 6.7 8.8 5.2
16 years 9.0 11.3 7.3
17 years 11.0 13.8 8.8
Trends in alcohol and cannabis use among Irish 
school-aged children, 1998–2014
The percentage of school-aged children reporting having 
ever had an alcoholic drink has decreased steadily since 
1998, especially among 13–15-year-olds (Figure 4). In 1998, 
65.6 per cent of 13–year-olds and 72 per cent of 14–year-
olds had ever consumed alcohol, compared to 23.2 per 
cent and 37.6 per cent respectively in 2014. However, the 
incidence of alcohol use among 17-year-olds remained 
consistent throughout the five time periods.
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Levels of lifetime drunkenness have also decreased and 
this is most apparent among 13–15-year-olds. There is less 
variation among 17-year-olds (Figure 5) Similar to alcohol, 
there has been a steady decrease in the lifetime use of 
cannabis among 13–17-year-olds. This decrease can be 
observed across all ages (Figure 6).
 
Overall, there was a decrease in self-reported alcohol and 
cannabis use among school-aged children in Ireland in 
2014 when compared to 2010 and earlier surveys. This 
may represent a true decrease, possibly owing to children 
having less pocket money in recent years because of the 
recession, or it may be the result of sampling variation, or a 
combination of both factors. 
These decreases are welcome, especially among younger 
teenagers, as the immaturity of their brains makes them 
particularly vulnerable to the harmful effects of alcohol. 
Delaying initiation of drinking also decreases the likelihood 
of developing alcohol dependence in later life. However, 
it is important to note that substance use is still common 
among Irish school-aged children, with one in five 17-year-
olds using cannabis in the previous year and 60.5 per cent 
having ever been drunk. Efforts to reduce Irish school-aged 
children’s substance use need to continue. 
(Deirdre Mongan)
1  Gavin A, Keane E, Callaghan M, et al. (2015) The Irish Health 
Behaviour in School-aged Children (HBSC) study 2014 Dublin: 
Department of Health and National University of Ireland, 
Galway. www.drugsandalcohol.ie/24909/ 
2  Perry C, Keane E and Nic Gabhainn S (2015) Short report HBSC 
Ireland 2014. Alcohol and cannabis use in school-children in 
Ireland. Galway: Health Promotion Research Centre, National 
University of Ireland, Galway.
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Women and addiction 
On 13 November 2015 the Dublin Business School (DBS) 
held a day-long conference on women and addiction.1 
The conference sought to explore the challenges faced by 
women in addiction by promoting dialogue about the issues 
experienced by these women in contemporary Ireland, and 
about the challenges faced by those working in the field. 
The conference brought together practitioners, students, 
volunteers, and individuals and groups with an interest in 
women and addiction.
The conference was divided into two themes, which 
ran concurrently: women in addiction, and women in 
recovery. During the morning a number of speakers shared 
their knowledge, expertise and practice of working with 
women in addiction in Ireland. At the end of the morning 
session, RADE (Recovery through Art, Drama, Education) 
participants performed their own drama, Get stoned, which 
challenges stereotypical perceptions of drug users, law 
enforcement, the community and politicians with regard to 
drug use. The afternoon session was comprised of a series of 
workshops,followed by a showcase of available services by a 
number of treatment service providers.
This article provides a brief overview of the ‘Women in 
Recovery’ theme. The opening address on the ‘women in 
recovery’ theme was given by the Dean of the DBS, who 
welcomed delegates, provided an overview of the college 
and applauded the students on the MA in Addiction Studies 
for organising the conference.
Gary Broderick, director of the Saol Project, spoke about 
trauma-informed care for women. Saol is the first woman-
specific, feminist drug rehabilitation project in Ireland and is 
located in Dublin’s north inner city. It is for women who are 
seeking to recover from drug use and promotes the needs of 
female drug users and their children. Mr Broderick discussed 
how the needs of women who use drugs differ from those 
of men. 
Many women who abuse drugs do so as a result of a 
specific traumatic event, such as physical or sexual abuse. 
Therefore ‘trauma-informed care’ is required to ensure 
interactions with women are informed by the impact of the 
trauma that they have experienced. Gary spoke about Lisa 
Najavitis’ manual Seeking safety,2 in which she suggests that 
99 per cent of women attending addiction services have 
experienced trauma and that 50 per cent will be found to 
have post-traumatic stress disorder (PTSD). Gary highlighted 
that recovery for women is more complex, quite often 
because of the role they play in their families.
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Drawing on findings from research, Dr Marguerite Woods 
focused on the image of women as users of drugs and as 
mothers, their experiences of stigma, their interactions with 
services, and the impacts of women’s drug use on their 
parenting role and relationships with others. The difficulties 
faced by women who use drugs include the stigma which 
is attached to being a mother who uses drugs, fears about 
the impact their drug use might have on their children 
and fears of losing their children because of their drug 
use. Dr Woods said that women who use drugs are often 
portrayed as villains rather than victims, and are viewed as 
victimisers of others, especially their children. Regarding the 
implications for policy and practice, Dr Woods highlighted 
the importance of addressing a woman’s needs rather 
than, or as well as, the needs arising from their drug use 
for their children and others. Gender-specific issues require 
exploration as do the issues of domestic abuse and a life 
after drug use for women. 
Mary O’Connor, governor of the Dochas Centre in Mountjoy 
Prison, Dublin, spoke of the needs of women in prison. She 
described the process that occurs when a women is taken 
into custody at the Dochas Centre. She said some women 
see prison as a means to accessing drug treatment, a safe 
haven where they can access services such as a GP, dentist 
or other specialist clinic. Ms O’Connor said the neediest of 
those in custody are more likely to be homeless, addicted to 
legal or illegal substances, and their imprisonment usually 
relates to their being a nuisance as well as a danger to 
themselves rather than their being a danger to society. 
(Ita Condron)
1  Further information on the Dublin Business School is available 
at http://www.dbs.ie/ 
2  Najavitis L M (2002) Seeking safety: a treatment manual for 
PTSD and substance abuse. Guilford, New York. http://www.
drugsandalcohol.ie/3597/ 
Grandparents caring full-time for 
grandchildren owing to parental drug use
No research had been done in Ireland on the issue of 
grandparents caring full-time for their grandchildren in 
situations where parents are substance abusers before the 
study described here was undertaken.1 Intending their 
research to be an initial contribution, the authors of this 
study sought to examine:
 ■  How do grandparents assume the caring role for their 
grandchildren?
 ■  What do grandparents identify as the positive aspects of 
occupying this role, as well as its associated stresses and 
strains?
 ■  How satisfied or dissatisfied are grandparent carers with 
the support they receive from the child protection service 
and, to a lesser extent, from addiction treatment services?
Participants were recruited through the National Family 
Support Network (NFSN), the national co-ordination body 
for a network of locally-based family support groups. To be 
included in the study the grandparents had to have been 
providing full-time care to grandchildren for at least six 
months, and to have taken on the caring role because of the 
parent’s drug use. Eleven participants (nine individuals, one 
couple) came forward, and 10 semi-structured interviews 
were conducted using a qualitative approach. After 10 
interviews the authors decided that saturation point had 
been reached and any additional participants were unlikely 
to reveal new information. As the first author was an 
employee of NFSN, a number of robust measures were 
implemented to reduce bias, including involving a researcher 
who was not an NFSN employee. 
The main themes and sub-themes that emerged from the 
interviews were: 
 ■ the decision to care
 ■ the challenges of being grandparent carers 
 − health and behavioural needs of grandchildren
 − financial difficulties
 − relationships with the family
 − physical and mental health problems
 ■ support from social and health services 
 − the child protection system
 − addiction services
 − financial payments from statutory bodies. 
This article will focus on two themes – the decision to care, 
and the grandparents’ experiences of interacting with 
addiction services.
Decision to care
Most grandparents became carers because of a sense of 
responsibility, to keep their grandchildren out of non-
relative foster care, or to ensure that the children received 
an adequate level of care that they were not receiving from 
their own parents.
The HSE…gave me a phone call one morning from [sic] 
work, and when I came home they had the two children 
in my sitting room with a carrier bag; and it was take 
them for three months or they were going into care….
it was a shock.
Addiction services
Participants in the study had mixed views on the addiction 
services they had encountered during their time as carers. 
Centralised treatment facilities and residential centres were 
viewed much more negatively than local addiction services. 
Some participants held the view that addiction services 
were unwelcoming to relatives, and that the services 
were reluctant to challenge their children regarding their 
negligence as parents. Some of the participants had funded 
several residential treatment stays for their child: 
Women and addiction (continued)
18
drugnet 
Ireland
We paid for private rehab … you name it she has 
been in it. It must been 14 rehabs. One of them, we 
re-mortgaged our house for €10,000 and sent her to 
Liverpool. She walked out after a week.
On a more positive note, family support services, which were 
normally located in community-based addiction services, 
were accessed by eight of the participants and were highly 
valued by those who accessed them. Grandparents learned 
about concepts of addiction for the first time, although this 
was often in an unstructured manner. ‘Enabling’ was the 
concept most mentioned by participants. Having learned 
about it, many grandparents began to refuse requests 
from their child for monetary or other forms of assistance. 
The authors noted that grandparents did not perceive the 
introduction of the concept of enabling as placing primary 
blame on them for their children’s drug use.
A related theme to emerge from the study was the relationship 
between child protection services and addiction services. The 
authors noted in the introduction to the report that in Ireland 
there is an absence of integrated responses to addiction and 
child protection issues. This issue was highlighted by the 
participants, with specific complaints about the lack of expertise 
among child protection social workers in relation to addiction. 
Conclusions
The authors concluded that the participants faced several 
hardships in their role as carers. These included mental health 
difficulties, refusal of support from statutory bodies, and 
difficulty accessing statutory payments and the associated 
financial difficulties. The authors suggested that many of these 
difficulties could be addressed without any further research. 
More cooperation between child protection and addiction 
services, including the capacity of non-specialist social service 
and health professionals to deal with addiction issues, could 
help alleviate the difficulties faced by grandparents. 
(Martin Grehan)
1  O’Leary M and Butler S (2015) Caring for grandchildren in 
kinship care: what difficulties face Irish grandparents with 
drug-dependent children? Journal of Social Work Practice in the 
Addictions (15): 352–372. http://www.drugsandalcohol.ie/24949/ 
Methadone-maintained patients in 
primary care
The use of primary health services by methadone-maintained 
patients (MMPs) is an under-researched area internationally. 
The aim of the study described here, conducted by 
researchers in Trinity College Dublin (TCD), was to examine 
this issue in the Irish context using a matched case-control 
study.1 The researchers particularly looked at chronic disease 
and multi-morbidity among MMPs.
TCD maintains a research network of GP practices throughout 
the greater Dublin area. Thirteen practices in this network 
have electronic patient records and provide methadone 
maintenance treatment (MMT). All 13 agreed to participate.
An MMP had to have attended the practice for both MMT 
and primary health care for at least one year to be included 
in the study. In total, 207 MMPs met the criteria, and were 
matched with 207 controls according to sex, age, practice 
(to account for geographical variability), and eligibility for 
the General Medical Services (GMS) scheme. The authors 
considered the combined sample size of 414 one of the 
major strengths of the study.
Information collected about participants from electronic 
records included demographic details, chronic disease data, 
repeat medications, and information relating to smoking, 
alcohol use, and non-opiate drug use. A number of variables 
related to health service utilisation were also recorded, such 
as number of GP and nurse consultations, referrals to hospital, 
and use of the out-of-hours GP service. Data were extracted 
from the electronic system using an in-depth form, which 
included reading all consultation notes. The authors reported 
some issues with data collection that may have resulted in the 
under-estimation of some of the variables, especially MMP 
outpatient attendances. In addition, specialist medicines were 
excluded from the analysis owing to a lack of systematic 
documentation in the 13 practices. Statistical tests conducted 
included independent samples t-tests, Pearson chi-squared 
tests, risk estimation, odds ratios (OR), 95% confidence 
intervals (CI) and binary logistic regression. 
There were no statistically significant differences in 
demographics between the MMP group and the control 
group: 43% of the sample was female, 57% male; 16% were 
private patients, 84% GMS patients.
Chronic disease and multi-morbidity
By comparing means using t-tests and OR, the authors 
presented evidence for the increased likelihood of chronic 
illness among MMPs versus controls. Compared to controls, 
MMPs were statistically significantly more likely to have:
 ■ chronic disease (OR 9.1 [CI 5.4 – 15.1])
 ■  multi-morbidity, i.e. two or more chronic diseases (OR 
6.6 [CI 4.3 – 10.2])
 ■ repeat medications (OR 5.8 [CI 3.7 – 8.9])
 ■ history of smoking (OR 4.8 [CI 3.2 – 7.2])
 ■ excess use of alcohol (OR 2.9 [CI 1.6 – 5.2])
 ■  non-opiate problem drug use  
(OR 141.2 [CI 63.3 – 315.3])
 ■ psychiatric disease (OR 6.1 [CI 3.9 – 9.3])
 ■ respiratory disease (OR 3.3 [CI 1.9 – 5.9])
 ■ infectious disease (OR 118.5 [CI 28.8 – 489.9])
It is of note that while MMPs were significantly more likely 
to have a chronic disease (OR 9.1 [CI 5.4 – 15.1], (95% CI), 
compared to controls, if HIV, and hepatitis B and/or C were 
excluded, then the OR was less emphatic, dropping to 4.2 
(CI 2.7–6.4). As expected, the OR for problem use of non-
opiate drugs was highly significant, 141.2 (CI 63.3–315.3).
Grandparents as carers (continued)
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MMPs have a lower average incidence of cardiovascular 
disease (0.06 vs 0.14, p=0.04), although the OR for this 
same category is not significant. This seems to indicate that 
MMPs may have lower levels of cardiovascular disease than 
controls, which seems counter-intuitive given the reported 
differences in the incidence of chronic diseases, and the 
history of smoking and respiratory disease. While the authors 
did not explicitly comment, they did observe that often 
medical problems among MMPs emerge as ‘unanticipated 
“door-handle symptoms” during time-pressured, protocol-
driven methadone appointments’ .
The authors constructed several binary logistic regression 
models. Of most interest was the model for chronic 
disease occurrences, age, sex, GMS status, current dose of 
methadone, and smoking. The model was restricted to MMPs 
only and the strongest predictor of chronic disease was being 
a GMS patient with an OR of 7.2 (CI 2.4–22.0). The authors 
concluded that the data suggested that GMS patients were 
sicker than non-GMS patients. A link to deprivation was also 
suggested, though the authors noted that non-GMS MMPs 
may have been part of a sub-group of MMPs who had shown 
increases in health and income owing to MMT. 
Health service utilisation
MMPs used their primary care facility on average 32 times a 
year and, of these, 30 were for MMT. Controls on the other 
hand had an average of only three visits a year. Visits were 
broken into three non-mutually exclusive categories to allow 
comparisons – ‘medical’, ‘nursing’ and ‘methadone’. MMPs 
were more likely to have attended for medical or nursing 
assessments. The majority (87%) of medical assessments 
and 20 per cent of nursing assessments took place during an 
MMT consultation. 
The study concluded that MMPs cost the health service as a 
whole more than the baseline cost of MMT:
MMPs had higher levels of health service utilisation  
at a practice and secondary care level. They generated a 
higher workload for GPs and increased administrative tasks 
for primary care services. They spent more time in emergency 
departments, inpatient beds, and outpatient clinics.
Conclusions
The authors concluded that health care policy must reflect 
the fact that MMPs are attending GP practices more often 
than non-MMPs, the strain this places on those services, and 
the risks associated with a singular focus on drug-related 
issues. The main recommendations of the authors included 
a more holistic approach to integrating MMT with general 
medical needs, and the promotion of better record-keeping 
with regard to chronic diseases. The authors identified an 
opportunity to increase the role of the GP practice nurse as 
the study suggested this resource was under-used in MMT. 
They also suggested that GPs should be offered incentives 
to be trained in MMT and any formal review of MMT GP 
remuneration should take into account the additional 
workload of taking care of MMT patients.
(Martin Grehan)
1  O’Toole J, Hambly R, Cox AM, O’Shea B and Darker C 
(2014) Methadone-maintained patients in primary care have 
higher rates of chronic disease and multimorbidity, and use 
health services more intensively than matched controls. The 
European Journal of General Practice (20): 275–20. http://www.
drugsandalcohol.ie/24352/ 
Overdose risk among heroin users:  
a pilot prevention study
The main cause of death among injecting drug users (IDUs) is 
opiate-related overdose. Some of the most common risk factors 
for overdose are age, gender, injecting drug use, drug purity, 
low tolerance, polydrug use, and recent imprisonment/release 
from prison. Problem drug users with a history of self-harm are 
also at increased risk of overdose. 
A study in two Cork addiction services aimed to investigate 
injecting drug users’ experience of fatal, non-fatal, accidental 
and intentional overdose and to ascertain the requirement for 
any overdose prevention training and resuscitation skills.1
There were three phases to the study, which was part of an 
internal audit of service users. 
 ■  Phase one explored the experience of overdose among 52 
service users attending the centres in 2012, measured their 
understanding of appropriate responses to overdose and 
assessed any need for resuscitation training. Questions were 
asked about the service users’ lifetime and recent (last six 
months) experience of non-fatal, accidental or intentional 
overdose, and the drugs involved. 
 ■  Phase two consisted of playing a DVD training programme 
on overdose prevention in the waiting room of the two 
centres for four weeks. After this, 26 services users out 
of the original 52 interviewed were re-interviewed about 
their overdose awareness and resuscitation skills. 
 ■  Phase three was a pilot training project of practical 
resuscitation skills and overdose prevention aimed at  
both service users and staff, which took place in 2013.  
In all, 14 service users, 10 family members and two staff 
took part in this phase.
Results of phase one were as follows:
 ■ 60% had ever overdosed.
 ■ 10% had overdosed in the previous six months.
 ■ 80% of overdoses were accidental.
 ■ Heroin was involved in 60% of all overdoses.
 ■ Benzodiazepines were involved in 47% of all overdoses.
 −  Benzodiazepines were more commonly reported in 
intentional overdoses (83%).
 ■ 56% had witnessed a non-fatal overdose.
 −  52% of non-fatal overdoses occurred in a private dwelling.
Methadone-maintained patients (continued)
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 ■ 19% had witnessed a fatal overdose.
 −  87% of fatal overdoses witnessed occurred in a private 
dwelling.
 ■ Of those who had witnessed an overdose,
 − 80% called an ambulance, and 
 −  55% reported putting the person into the recovery 
position.
 ■ 54% reported never or rarely worrying about overdose.
 ■ 92% knew what number to call for an ambulance.
 ■ 62% reported they knew what the recovery position was.
 ■  65% reported an interest in learning basic  
resuscitation skills.
Results of phase two showed that after the intervention, 100% 
of participants knew what number to call for an ambulance, 
and 73% knew what the recovery position was. 
For phase three, a brief evaluation and a focus group were 
conducted. The outputs highlighted a number of issues to 
be considered when considering how to prevent overdose 
risk behaviours – release from prison; polydrug use; the 
psychological effects of the experience of overdose for service 
users, for example the death of friends; the need for overdose 
prevention training for service users in order to equip them 
with the skills to prevent fatal overdoses; and the need for 
training and development for professionals working at the 
points of contact, for example in emergency departments. 
While the sample size was small, and the study relied on self-
reported answers, the participant responses were similar to 
those in other studies on overdose prevention. The authors felt 
that studies like theirs play an important part in understanding 
the dynamics of overdose in Ireland and highlight the need 
for overdose prevention training. They recommended the 
provision of intranasal naloxone to service users attending 
needle exchange and the consideration of supervised injecting 
rooms.2 The authors concluded that providing overdose 
prevention training and basic resuscitation skills can have a 
positive outcome not only for the individual but also for their 
peers and the wider community. 
(Suzi Lyons)
1  Horan J, Deasy C, Henry K, O’Brien D and Van Hout MC (2015) 
Overdose risk perceptions and experience of overdose among 
heroin users in Cork, Ireland. Preliminary results from a pilot 
overdose prevention study. Heroin Addiction and Related Clinical 
Problems (17): 19–26. http://www.drugsandalcohol.ie/24795/ 
2  On 15 December 2015 the Irish government approved 
additional heads for inclusion in the Misuse of 
Drugs(Amendment) Bill 2015 to allow for supervised injecting 
facilities in Ireland. http://health.gov.ie/blog/press-release/o-
riordain-welcomes-government-approval-for-medically-
supervised-injection-facilities/ 
Community Alcohol Response 
and Engagement 
On 27 October 2015 Aodhán Ó Ríordáin TD, Minister of 
State for Equality, New Communities and the Drugs Strategy, 
launched the evaluation report on the Community Alcohol 
Response and Engagement (CARE) alcohol treatment project.1 
The CARE project was a cross-task force initiative funded by the 
HSE. Its aim was to provide cross-disciplinary support across 
three task force areas – Ballymun, Finglas and North County 
Dublin – to clients seeking to address problematic alcohol use. 
The project was rolled out between September 2014 and  
June 2015.
The CARE programme involved out-patient medical and 
psycho-social treatments tailored to the needs of individual 
clients. The treatment pathway followed a five-step process:
 ■ referral,
 ■ initial assessment and AUDIT, 
 ■ comprehensive assessment, 
 ■ care planning, care giving and referral, and 
 ■ aftercare and exit planning. 
Clients were given an initial assessment using the NDRIC-
endorsed AUDIT system.2 Those who scored 14 or below 
were given brief advice and guidance while those scoring 15 
or higher were put forward for a comprehensive assessment. 
The comprehensive assessment gauged the clients’ needs 
in relation to a number of factors including their history of 
drug and alcohol use, medication, social circumstances, risk-
screening and goals. Once the comprehensive assessment 
was completed, a member of the care team was assigned to 
develop a care plan in line with the client’s needs and goals. 
Finally, aftercare was provided to those clients who required 
continued psycho-social support along with exit planning to 
cease engagement with the CARE team.
The effectiveness of the pilot programme was evaluated using 
several different methods. The researchers reviewed clients’ 
case files (n=105), undertook client interviews (n=6) and 
conducted a client audit (n=40). With regard to professionals 
and policy makers, the researchers conducted interviews 
(n=13) and surveys (n=38). The final document incorporated 
feedback from these stakeholders. 
In total, 142 clients were referred to CARE, and of these, 105 
(74%) attended for the initial assessment. GPs accounted 
for 40 per cent (42) of referrals who attended for the initial 
assessment, while psycho-social partners accounted for 34 
per cent (36); in all three sites, the lowest number of referrals 
who progressed on to an initial assessment came from among 
the clients themselves. Of the 105 people who attended their 
first appointment, 104 people (99%) completed the initial 
assessment (one person was referred to A&E and received no 
further care).
The gender breakdown of those who attended for an initial 
assessment (n=105) was almost even, with 52 per cent male 
and 48 per cent female. The median age was 45 years. Over 
half (56%) were unemployed. A significantly higher proportion 
of people were employed in the North County Dublin cohort 
(56%) than in Finglas (34%) or Ballymun (19%). 
Overdose prevention (continued)
21
drugnet 
Ireland
AUDIT scores were taken for 100 of the clients who attended for 
initial assessment, and 86 per cent were deemed to be alcohol 
dependent. Of the 89 clients attending for initial assessment 
who consented to urinalysis, 49 per cent tested positive for drugs 
other than alcohol. Of these, benzodiazepine was by far the most 
common drug, present in 37 per cent of clients, followed by 
cannabis (11%). 
Table 1 illustrates the services that the clients who attended for 
the initial assessment availed of across the whole programme. Of 
the 105 clients for whom an initial assessment was offered, 92 
(88%) also received psycho-social supports from a partner site, 
with the exception of 13 (13%) who declined this support or 
already had an alternative source for this support. Eighty-two of 
those who attended for an initial assessment (78%) went on to 
complete the comprehensive assessment.
Table 1: CARE service provision to clients across the whole 
programme (n=105)
Service Type Number (%)
Comprehensive assessment 82 (78)
Mental health assessment 67 (64)
Physical health assessment 96 (91)
Blood testing 66 (63)
Urinalysis 89 (85)
Mental health referral 23 (22)
Physical health referral 32 (31)
Referral to residential alcohol 
services
12 (11)
CARE detoxification 23 (22)
Completed CARE Detox 18
Disengaged CARE Detox 5
Pharmacological Treatment 
(percentage of 105)
22 (21)
Detoxification support for 
non-care detox
20 (19)
Alcohol awareness group 17 (13 clients;  
4 family members)
Sober Skills Group 9 (6 CARE; 3 non CARE)
Source: Dermody and Banka 2015: pp. 41 & 43 
The case audit of the 40 client files found that all clients had a 
care plan, and 80 per cent had multiple goals. The main goals are 
summarised below.
 ■  39 clients (98%) had alcohol reduction as a goal, of whom 
36 (92%) had made progress towards the goal and 32 (82%) 
had made significant progress in reducing alcohol intake, 
with over half of these clients becoming abstinent and over 
half maintaining abstinence.
 ■  18 clients (45%) identified pro-social engagement (being 
able to participate in social activities without focusing on 
alcohol consumption) as a goal. Half of these clients reported 
progress in this area. 
 ■  16 clients (40%) had improving relationships with family as a 
goal, of whom 11 (69%) reported progress, with 10 of these 
showing minor improvement and one showing significant 
improvement.
The report found that the opinions of the professionals involved, 
e.g. psycho-social workers and GPs, were universally positive 
towards CARE. Improvements in knowledge, skills, care planning 
and more effective referrals were all cited as positives from the 
programme. Value for money was also cited as a positive of the 
programme as it used services and resources already available.3 
The project had a number of limitations. Only 40 client cases 
were explored in depth, with an even lower number of in-depth 
interviews with professionals and policy makers. It is difficult to 
assess the success of a project based on such a small sample. 
Recall bias on the part of staff performing the case file analysis 
was not controlled for, as the analysis was not based on pre- and 
post-programme data collection but was drawn from the staff’s 
own subjective perspective, either from memory or from written 
case notes/files. As there was an absence of pre- and post-
programme data, it was also difficult to gauge the impact of the 
project on the clients. Family members were mostly reluctant to 
engage with the project, which meant analysis of the project’s 
impact on family members was not possible. Lastly, although 
the project ran for a year in the three task force areas, the service 
had only been rolled out in one of the pilot sites for 5–6 months 
by the time the evaluation was undertaken. Thus, there was 
insufficient data from this site to provide the same level of detail 
regarding its effectiveness compared to the other sites. 
The authors also highlighted challenges in the project to do 
with time and resources. There were bottlenecks in the delivery 
of some support services, which led to clients having to go 
on waiting lists, and a lack of resources was deemed to have 
impacted on the delivery of the programme. Some participants 
highlighted a lack of clarity regarding certain parts of the 
programme despite protocols and governance frameworks being 
in place. Lastly, data collection was seen as an issue which would 
need to be addressed. 
Following the evaluation, the authors made a series of 
recommendations including the following:
1.  increase clinical nursing hours and psycho-social support;
2.   develop a training manual to strengthen the clarity of 
protocols, particularly policy and procedures in relation to key 
working and client-related communication; 
3.   add pre- and post-participation measurement scales in order 
to allow more effective measurement of client progress, 
ideally through use of an information system; and 
4.   measure the economic and wider social impacts of the CARE 
programme. 
The CARE programme pilot was deemed a success and a highly 
valued addition to community alcohol treatment. The authors 
stated that the programme was consistent with local and national 
strategic goals in relation to alcohol treatment in the community, 
and felt that it could easily be replicated in other areas. 
(Derek O’Neill)
1  Dermody A and Banka P (2015) Evaluation of CARE (Community 
alcohol response and engagement) pilot project Dublin: Ballymun 
Local Drugs & Alcohol Task Force and Quality Matters. http://
www.drugsandalcohol.ie/24700/ 
2  AUDIT is a test designed to determine if a person is at risk of 
alcohol abuse problems. The higher the overall AUDIT score, the 
more problematic a person’s drinking is thought to be. In general, 
AUDIT scores between 8 and 15 indicate a medium level of alcohol 
problems, with 16 and above seen as indicating alcohol dependence 
and warranting further evaluation and treatment. NDRIC is the 
National Drug Rehabilitation Implementation Committee. 
3  The total cost of the project was €116,000, of which €97,725 
was staff costs (1 full-time co-ordinator and 1 FTE clinical nurse 
specialist).
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Drug and Alcohol Awareness Week  
in the Midlands 
The Midland Regional Drugs and Alcohol Task Force (MRDATF) 
ran its annual Drug and Alcohol Awareness Week from 9 to 14 
November 2015. A total of 29 events were organised across 
counties Longford, Westmeath, Laois and Offaly.1 
The awareness week was launched by Susan Scally, Principal 
Officer, Drugs Policy Unit, Department of Health, who stated 
at the launch in Athlone:
I am delighted to be here today to launch the Drug and 
Alcohol Awareness Week and would like to congratulate 
the Task Force and all the partner agencies for running 
this annual campaign. I especially welcome the focus on 
educating young people about the consequences of drug 
and alcohol misuse and the range of events which are 
designed to encourage young people to discuss the issues 
involved in an open and frank way.
The primary role of the MRDATF, which is funded by the 
Department of Health, is to research, develop, implement 
and monitor a co-ordinated response to the problem of 
drug and alcohol misuse as experienced in the four midland 
counties. The aim of the awareness week is to increase 
awareness of drug- and alcohol-related issues and to 
highlight the drug and alcohol support services available. 
The 29 events were organised by the MRDATF and 
community, voluntary and statutory agencies across the 
midland region. Each event had a specific target audience – 
service providers, the general public, parents, students and 
under-18s. The County Longford Drug and Alcohol Forum 
hosted a ‘Strength in local knowledge’ seminar at which 
their new service information poster was launched. Several 
sessions were held on ‘suicide alertness’, targeting everyone, 
and also a ‘responding to intimidation’ seminar. 
Dr Susan Redmond, a leadership coach and consultant 
based in County Galway, held meetings in several locations 
on ‘Connecting with your teenager – mindfulness for parents 
during adolescent development’. In addition, there were 
cultural, musical and art events.
Cannabis conference
On the morning of the launch Susan Scally also opened a 
cannabis conference, The facts about cannabis. Organised by 
the MRDATF and HSE CADS (Community Alcohol and Drug 
Service), the aim of the conference was to bring together 
interested individuals and agencies working in the field of 
addiction to engage in meaningful learning and discussion 
regarding the impact of cannabis use on the individual  
and society. 
Guest speakers at the conference included:
 ■  Dr Suzi Lyons, senior researcher, National Health 
Information Systems (NHIS) in the Health  
Research Board
 ■  Dr Adam R Winstock, founder of the Global Drug Survey, 
and consultant psychiatrist and addiction medical 
specialist at the South London and Maudsley NHS Trust
 ■  Philip James, clinical nurse specialist, HSE YoDA (Youth, 
Drug & Alcohol) Service
Dr Winstock said at the conference:
The cannabis story is changing. From new preparations 
and methods of use to synthetic cannabinoids and 
regulated markets cannabis has never been so 
interesting. There’s so much that can be done to better 
educate users and health care providers to help people 
use more safely and help those who need treatment get 
the right help. I hope I can support all in attendance at 
the Cannabis Conference today to do that.
(Suzi Lyons and Antoinette Kinsella)
1  For more information on the MRDATF visit  
http://www.mrdatf.ie/index.php 
Attending the MRDATF’s annual Drug and Alcohol Awareness 
Week were (L-R) – Dr Suzi Lyons, Senior Researcher HRB, Dr 
Adam Winstock, Founder Global Drug Survey, Consultant 
Psychiatrist & Addiction Medicine Specialist, Antoinette Kinsella, 
Co-ordinator MRDTF, Peter McEvoy, Chairperson MRDATF, 
Susan Scally, Principal Officer, Drugs Policy Unit, Department of 
Health, Philip James, Clinical Nurse Specialist, HSE YoDA, Fran 
Byrne, Regional Manager HSE CADS
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Culture and organisation in the  
Irish Prison Service
Culture and organisation in the Irish prison service: a 
road map for the future, a new report completed by the 
Inspector of Prisons, Judge Michael Reilly, and Professor 
Andrew Coyle, Emeritus Professor of Prison Studies at 
the University of London, examines all aspects of the 
administration and governance of the Irish prison system 
and identifies a number of deficiencies in administration, 
treatment of prisoners and delivery of services by prison 
staff.1 The authors are particularly critical of inadequate and 
misleading reporting, a direct result of the absence  
of functioning line management structures in many  
prisons and a factor contributing to consistent breaches  
of agreed procedures. 
The review examines several aspects of the work of the 
3,380 staff in the Irish Prison Service (IPS), most of whom 
are prison officers, and recommends significant changes 
to management structures, career progression and staff 
reporting. It recommends substantial changes to the prison 
system’s governance structures, in particular with regard 
to the manner in which the IPS reports to the government, 
the appointment of IPS board members and regional 
management structures. 
Healthcare services
Recommended reforms include appointing a Director of 
Prison Healthcare Services, the person appointed to be 
a registered medical practitioner. The report notes that 
many prisoners have a poor health profile and providing 
adequate medical and nursing care in prisons presents 
significant challenges. The work of healthcare staff within 
the prisons system will be key to progress in this area: 
while there has been a steady increase in specialist civilian 
staff replacing prison officers in recent years, Irish prisons 
have been much slower than those in the United Kingdom. 
Nursing managers in the larger prisons lead teams of 
qualified nurses and there are 111 nurses currently working 
in the prison service, with 27 nursing places unfilled.
In contrast to countries like Norway and Scotland, which 
adhere to international standards relating to the provision 
of healthcare services in prisons, medical services in 
Irish prisons are not integrated with the general health 
administration in the community, and prison health policy 
is not necessarily compatible with national health policy. 
The authors cite a 2009 Health Service Executive (HSE) 
report, which recognised that the HSE was peripheral to 
prison healthcare delivery.2 Recommendations on providing 
a clear definition of the role of prison nurses have not 
been implemented and staffing shortages and changes 
in conditions of employment have contributed to the 
frustration of nurses, unable to provide the level of nursing 
care they would wish.
Relationships between management and staff
The report observes that progress from a command 
structure to a management structure in the prison 
service lagged far behind that in other areas of public 
administration. Promotions have traditionally been through 
the ranks and there has been a blurring of the distinction 
between staff and management. Many officers spoke 
of an inflexible culture with an emphasis on ensuring 
things didn’t go wrong, not on introducing new thinking. 
Promotion to a higher grade generally operates on a 
generic basis. This means that it has been possible for 
someone who has spent all of their career to date in a 
specialism, with minimal direct contact with prisoners or 
little management of staff, to be promoted to assistant 
governor or to one of the grades of chief officer and 
then be appointed to a position that requires first-line 
management of both staff and prisoners. A number of 
recently appointed assistant chief officers reported that 
they felt unprepared for their new responsibilities and 
that they found it difficult to gain appropriate respect 
from some other officers and even from prisoners. The 
chapter on staff learning and development highlights the 
disparity between employment practices in the prison 
system and the wider public service. It appears that PMDS 
(Performance Management and Development System) 
forms are not filled and after their initial training staff 
learning and development is not monitored.
Prisoners
The focus of this review was on how the current culture of 
the Irish prison system contributes to or undermines the 
development of the prison service. Its terms of reference 
meant that the authors concentrated on organisational 
issues, the nature of prison work and the experiences and 
capacity of staff within the IPS. The prisoners themselves 
are the subject of just one chapter. It is clear that much 
progress has been made in recent years in improving the 
conditions in which prisoners live and in identifying and 
responding to areas of particular concern. The introduction 
of a new complaints procedure and thorough investigations 
of deaths are two recent advances in this regard.
Historically, the autonomy granted to individual Irish 
prisons has meant that, unlike other countries, where a 
prisoner’s destination is determined largely by an initial 
classification, prisoners in Ireland are usually allocated 
to the prison of first committal. The lack of a thorough 
individual assessment of prisoners militates against 
attempts to establish internal good order and, in some 
prisons, contributes the development of gang culture. 
Gang structures in prisons often mirror external affiliations 
and can be built around the distribution of drugs, 
threatening stability in the prison. There does not appear 
to be a clear operational strategy for dealing with gangs 
and individual staff members are unable to cope with the 
violence and intimidation that is part of gang activity. 
Often it is the victim, not the perpetrator, of this activity 
who is transferred to another prison or what is called a 
‘protective regime’.
Several issues relating to management of prisoners and 
their rehabilitation were beyond the scope of this review. 
The authors recommend that a separate review should 
deal comprehensively with these and should include the 
following in its terms of reference:
24
drugnet 
Ireland
MQI annual review 2014 
The Merchants Quay Ireland (MQI) annual review for 2014 
was launched on 11 September 2015 by Uachtarán na 
hÉireann, Michael D Higgins, on the occasion of his visit to 
MQI’s Drugs and Homeless Services.1 
MQI’s 18th annual review notes the continuing growth of 
homelessness and drug use. During 2014 MQI announced a 
number of developments and extensions to its services, most 
notably the establishment of The Night Café, completion 
of its client management system and the introduction 
of a dedicated mental health nursing position. MQI also 
published Examining the profile and perspectives of individuals 
attending harm reduction services who are users of performance 
and image enhancing drugs,2 which was launched in 
November 2014 by Susan Scally, Head of the Drug Policy 
Unit in the Department of Health.
MQI’s New Communities Support Service provided one-to-
one support to 350 service users mostly from East European 
countries. The largest number of new community clients 
were from Poland.
 
MQI’s needle-exchange service recorded approximately 
26,400 client visits in 2014. The report highlights the 
continuing high level of demand for homelessness services: 
79,636 meals were provided by the day and evening 
services, and 5,329 health-care interventions were provided.
The year 2014 saw MQI continue to provide its national 
prison-based addiction counselling service to 13 prisons. 
MQI successfully tendered and was awarded the contract 
to provide this service until 2017. Demand for the service 
continues to be high: 11,225 individual counselling sessions 
were provided, and 4,273 group attendances were recorded. 
In Mountjoy Prison, MQI’s counselling service co-ordinates 
an inter-agency programme in the medical unit; during the 
year, 52 prisoners availed of the service, with 43 completing 
the programme. 
MQI, in association with the Midland Regional Drugs and 
Alcohol Task Force and the Health Service Executive (HSE), 
administers the Midlands Family Support and Community 
Harm Reduction Service, providing outreach and working 
with families of those actively using drugs in that task force 
region. In 2014:
 ■  The family support service provided 212 group and 994 
individual sessions, and 302 supportive phone calls. 
 ■  The harm reduction service worked with 255 clients, 
providing 2,454 interventions. 
 ■  On average, 217 needle exchanges were provided each 
month. 
 ■  Athlone Open Door Centre had 144 clients, recording 
2,835 visits in total and providing 2,266 meals.
 ■  The Midlands Rehabilitation and Aftercare service worked 
with 76 individuals, providing 422 one-to one-sessions 
and 99 group sessions.
In 2014 MQI developed two other programmes in the 
Midlands region: 
 ■  The Day Programme is a Department of Social Protection 
Community Employment (CE) scheme and it worked 
with 10 individuals during the year.
 ■  The Resettlement Programme has established 
relationships with local property owners and MQI 
provides eight beds for individuals in recovery.
Table 1: Services offered by MQI, number of participants and outcomes, 2014 
Service Type of intervention Number of participants Outcomes
Needle-
exchange 
and health-
promotion 
services
 ■  Promotes safer injecting techniques 
 ■  HIV and hepatitis prevention
 ■ Safe sex advice
 ■ Information on overdose
 ■  Early referral to drug treatment services
3,179 used needle-exchange services, 
of which, 527 were new clients.
1,786 safer injecting workshops were 
provided.
Outreach  ■ Street contact work
 ■  Collecting used injecting paraphernalia
 ■  Liaison with various groups and 
professionals
 ■ Hospital visits  
Over 1,000 clients engaged with the 
outreach team. 
 ■ health care including mental health, 
 ■ drug and other substance abuse,
 ■ education and skills training,
 ■ the role of specialist staff in the prison environment,
 ■ a higher priority for pre-release planning, and
 ■  the parole system and the use of remission of sentence in 
the rehabilitation of prisoners. 
(Brian Galvin)
1  Office of the Inspector of Prisons (2015) Culture and 
organisation in the Irish prison service: a road map for the  
future Dublin: Office of the Inspector of Prisons.  
http://www.drugsandalcohol.ie/24803/ 
2  Health Service Executive Nursing & Midwifery Planning  
& Development Unit (2009) Nursing in the Irish Prison  
Service: working together to meet the healthcare needs  
of prisoners Dublin: Health Service Executive.  
http://www.drugsandalcohol.ie/12520/ 
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Missie Collins, one of the speakers at the Pavee Point 
celebration, with President Michael D. Higgins and  
Mrs. Higgins at the event
Table 1: Services offered by MQI, number of participants and outcomes, 2014 (continued)
Service Type of intervention Number of participants Outcomes
Primary 
healthcare 
services
 ■ Nursing
 ■ Counselling
 ■ GP service
 ■ Psychiatric nursing
1,804 nursing interventions.
811 counselling sessions.
1,985 GP consultations.
168 psychiatric nursing 
assessments 
Stabilisation 
services
Methadone substitution
Gateway programme
20
Not available
Aftercare  ■  Drug-Free Day Programme 
 ■  Weekly aftercare support group 
(post residential treatment in High 
Park and St Francis Farm)
19 clients admitted to the 
service
22 clients admitted to the 
service
55% completed the 
programme.
52% completed the 
programme. 
Integration 
programmes
 ■ Ballymount House
 ■  Leixlip House with Respond 
Housing Association
17 admissions to aftercare 
housing.
Occupancy rate for Ballymount 
and Leixlip was 84%.
Training 
and work 
programmes
Community Employment (CE) scheme 144 Of the 42 who completed 
placements at MQI, 8 secured 
permanent employment,
3 returned to education and 3 
moved to another course.
High Park 17-week, drug-free residential 
programme including individual 
counselling, group therapy, 
educational groups, work assignments 
and recreational activities
297 referrals (of whom 43 were 
admitted for detoxification)
8 clients received a Bronze An 
Gaisce Award.
St Francis 
Farm
Therapeutic facility offering a 14- 
week programme
Detox facility
357 referrals (of whom 46 were 
admitted for rehabilitation)
289 referrals (of whom 64 were 
admitted for detoxification)
67% completed the 
programme.
69% completed their detox.
  
(Ita Condron and Vivion McGuire)
1  Merchants Quay Ireland (2015) Annual review 2014. Dublin: MQI. http://www.drugsandalcohol.ie/24503/ 
2  Merchants Quay Ireland (2014) Examining the profile and perspectives of individuals attending harm reduction services who are users of 
performance and image enhancing drugs. Dublin: MQI. http://www.drugsandalcohol.ie/23024/ 
Pavee Point celebrates 30 years
The celebration of 30 years of Pavee Point Traveller and 
Roma Centre was kicked off by the President of Ireland, 
Michael D Higgins, on 18 November 2015.1 The President 
spoke about the work of the organisation and its pivotal role 
in the Traveller community, and how it had helped to make 
many positive changes over the past 30 years. 
Gabi Muntean (community development worker) spoke 
about the decision to include Roma in the organisation and 
to change the name to the Pavee Point Traveller and Roma 
Centre. Other speakers included Martin Collins (co-director), 
Stasia Crickley (chairperson) and Missie Collins (primary 
health care worker). Music was provided by Mickey and Brid 
Dunne and also by Roma musicians.
(Suzi Lyons)
1  For further information see http://www.paveepoint.ie/
president-helps-us-celebrate-30-years
Merchants Quay Ireland (continued)
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EMCDDA update
European conference on addictive behaviours 
and dependencies 
The first European conference on addictive behaviours and 
dependencies was held in Lisbon on 23–25 September 2015. 
It was jointly organised by the Portuguese General Directorate 
for Intervention on Addictive Behaviours and Dependencies 
(SICAD), the European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA), the journal Addiction, and the 
International Society of Addiction Journal Editors (ISAJE). The 
conference was organised around four general themes:
 ■ Addictions: a multi-disciplinary perspective
 ■ Translating research into policy and practice
 ■ New frontiers in addiction research
 ■ Challenges of addiction in an interconnected world
Over 600 participants, including researchers, practitioners 
and policy experts from 58 countries and a range of 
specialist areas including illicit drugs, alcohol, tobacco, 
gambling and other addictive behaviours, attended the 
event. Research was presented in a number of developing 
fields such as new psychoactive substances, online sales 
and gambling, cannabis legalisation and alcohol pricing. 
Following on from the success of this conference it is 
planned that the next European conference will be held in 
Lisbon in 2017. (Deirdre Mongan)
Presentations and e-posters from the conference available at 
www.lisbonaddictions.eu/start#downloads 
Prevention of addictive behaviours 
The latest volume in the EMCDDA Insights series and 
released ahead of Lisbon Addictions 2015, Prevention of 
addictive behaviours updates a previous edition Prevention of 
substance abuse, published in 2008. Both editions are based 
on a German study commissioned by the Federal Centre for 
Health Education (Cologne) and present a state-of-the-art 
review of prevention science. Although originally targeted at 
a German audience, the evidence base addressed is global 
in scope. The review is broad in its considerations, covering 
not only the central topic of drug abuse, but also alcohol, 
tobacco and behavioural addictions, such as gambling. 
Available in English at www.emcdda.europa.eu/publications/
insights/preventing-addictive-behaviours 
EMCDDA 20 years on
In 2015 the EMCDDA commemorated 20 years of 
monitoring the drugs problem in Europe. To mark the 
occasion, the agency has published a flyer presenting a brief 
summary of the agency’s key achievements since 1995. 
Over the last two decades, much has changed in the extent 
and nature of the drug phenomenon and the Centre’s work 
has developed to keep pace with this complexity. The text 
is complemented by an illustrative timeline highlighting a 
selection of major events presented by year. 
Available in English at www.emcdda.europa.eu/publications/
brochures/20-years 
Peter McVerry Trust annual report 2014 
The Peter McVerry Trust (PMVT) annual report for 2014 
was launched on 17 November 2015 by the Minister for 
the Environment, Community and Local Government, Alan 
Kelly TD.1 During 2014 the Trust continued to tackle a wide 
range of needs – homelessness, drug misuse and social 
disadvantage – through the provision of services in areas 
such as homelessness prevention, housing, accommodation 
for homeless people, drug treatment and under-18s 
residential services.
During 2014 the Trust opened at least one new service in 
each of its four core areas of service provision. These new 
services, combined with the rapid rise in the number of 
people presenting as homeless, resulted in a large increase 
in participant numbers: during 2014 the Trust engaged with 
almost 4,460 participants across its services, representing an 
increase of 24 per cent since 2013. 
Provision of drug treatment services is a crucial support 
for many participants. During 2014, 78 per cent of those 
accessing the Trust’s services had current or past experience 
of drug misuse. The Trust’s residential community 
detoxification service delivered support to 80 participants. 
These clients were admitted to the service seeking either 
detoxification from methadone or engagement with the 
residential cannabis cessation programme. This latter 
programme began in January 2013 as a direct response 
to the growing number of young people presenting with 
concerns about the impact of cannabis use on their lives.
PMVT continues to provide stabilisation and recovery 
services in both Dublin City and in North County Dublin, 
and 397 individuals availed of these services in 2014. Both 
services provide a safe and stable environment for young 
people over 18 years of age who wish to stabilise their 
problematic drug use. 
Participants on the Stabilisation Programme engage in 
psycho-educational and process groups, with the aim of 
increasing drug and health awareness. This is achieved 
through ongoing peer-to-peer and one-to-one support. 
The Swords Stabilisation Programme, which PMVT 
established in mid-2013, provides participants with access 
to two day programmes: an early relapse prevention 
programme, and the stabilisation programme. During its 
first full year, the new facility worked with over 100 people 
from the North Dublin area. The service provides links to 
other service providers in the region and is partly funded by 
the North Dublin Regional Drug and Alcohol Task Force.
For further information on the Peter McVerry Trust and the 
services it offers please access www.pmvtrust.ie 
(Vivion McGuire)
1  Peter McVerry Trust (2015) Annual report for 2014. Dublin: 
PMVT. http://www.drugsandalcohol.ie/24829/ 
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From Drugnet Europe
Lisbon Addictions 2015 – conference 
‘Addiction science in Europe is of growing policy relevance, 
becoming more mature in respect to capacity and quality 
and more influential in respect to its findings. Despite this, 
no multidisciplinary forum has existed until now to allow 
scientists working in the addictions area to share knowledge, 
to network and to present their latest findings...Now is a 
unique moment to establish a leading international forum on 
addictions’. These were the words of João Goulão, Director 
of the Portuguese General Directorate for Intervention on 
Addictive Behaviours and Dependencies (SICAD), at the 
opening of the first European conference on addictive 
behaviours and dependencies — Lisbon Addictions 2015 — 
held in the Portuguese capital from 23–25 September. 
Hosted by SICAD, the event was held in collaboration with: 
the scientific journal Addiction; the International Society 
of Addiction Journal Editors; and the EMCDDA. State 
Secretary to the Portuguese Ministry of Health, Fernando 
Leal Da Costa, officially opened the conference. The 
European Commission was represented by Floriana Sipala 
(DG HOME) and Philippe Roux (DG SANTE). In his opening 
speech, EMCDDA Director Wolfgang Götz declared: ‘Lisbon 
Addictions is a milestone for the European and international 
scientific community in the substance use and addiction 
field. In Europe, this is the first time that such a large 
multidisciplinary and cross-cutting event in this field has 
been organised and the EMCDDA is proud to be one of the 
main partners associated with making this possible’. 
Showcasing the latest developments in addiction science, 
the conference explored the topics of illicit drugs, alcohol, 
tobacco, gambling and other addictive behaviours. 
Researchers, practitioners and policy experts participated 
from 58 countries. … Addressing the closing session, 
EMCDDA Scientific Director Paul Griffiths said: ‘This 
conference has exposed us to the cutting-edge of new 
science occurring across the addictions field and has enabled 
us to forge new relationships from which, undoubtedly, 
many future collaborations will be born’. In his closing 
address, Deputy Director of SICAD Manuel Cardoso called 
for a ‘broad, global and integrated perspective on problems 
and responses in the field of addictive behaviours and 
dependencies’. He ended announcing the second European 
conference on addictive behaviours and dependencies, to be 
held in Lisbon in 2017.
For more, see www.lisbonaddictions.eu and www.youtube.
com/watch?v=ApQwlilCfNE
EMCDDA signs MoU with Georgian Ministry of Justice 
The EMCDDA and Georgia are set to cooperate more 
closely on monitoring the drug phenomenon, following 
a Memorandum of Understanding (MoU) signed on 4 
November in Tbilisi between the agency and the Georgian 
Ministry of Justice. The signatories were EMCDDA Director 
Wolfgang Götz and the Georgian Minister of Justice Tea 
Tsulukiani. The two bodies recognise that information on 
the drug phenomenon is an essential and indispensable 
instrument for drafting and implementing drug policies 
and for assessing the impact of actions to reduce problems 
originating from drug use and trafficking. The MoU 
provides for the: exchange of technical expertise and 
knowledge between the two institutions; co-sponsoring of 
technical meetings; and the pooling of human and financial 
resources to launch joint programmes. The agreement will 
be implemented through a joint work programme to be 
updated every three years. This is the fifth MoU to be signed 
between the EMCDDA and a country of the European 
Neighbourhood Policy area: agreements already exist with 
Armenia, Israel, Moldova and Ukraine.
For more, see Fact sheet No 9/2015 at www.emcdda.
europa.eu/news/2015/fs9/georgian-memorandum-of-
understanding 
Malta’s new drug law focuses on helping users 
A new ‘Drug Dependence (Treatment not Imprisonment) 
Act’ entered into force in Malta on 15 April, significantly 
changing the country’s legal framework for responding to 
drug use and drug-related crime. In introducing the Act, 
the Maltese government provides for the treatment of 
persons in possession of small quantities of prohibited drugs 
for personal use and, for some drug-related crimes, for the 
rehabilitation of persons suffering from drug dependence. 
Prior to the legislation, the Magistrate’s Court could 
issue a penalty of 3–12 months’ imprisonment and/or a 
fine for possession of drugs for personal use. Now, the 
Commissioner for Justice should issue an administrative 
penalty of EUR 50–100 for the possession of under 3.5 g 
of cannabis or of EUR 75–125 for under 2 g of other drugs 
(provided that there is no evidence of supply). 
A repeat offender possessing a drug other than cannabis 
will appear before the new Drug Offenders Rehabilitation 
Board, which may take various measures to help the 
offender recover from dependence. The Board is chaired 
by a retired judge or magistrate and has three members 
appointed by the Ministers of Home Affairs, Social Policy and 
Health respectively. The Magistrate’s Court, supported by 
the Board, may decide to assume the functions of a Drugs 
Court in defined cases (e.g. dependent offender, some drug-
related crimes). Here it may refer the offender to the Board, 
which would, in turn, manage the offender for up to 18 
months in recovering from dependence. After this, the case 
may be closed, or prosecution continued, accordingly. 
The Act also establishes: the removal of mandatory 
imprisonment for the cultivation of one cannabis plant for 
personal use; a Sentencing Policy Advisory Board (which 
aims to achieve consistency in court punishments for drug-
related offences); a legal basis for the prescription of licensed 
medical preparations of cannabis; and an exemption from 
prosecution for drug possession for anyone assisting a 
person suffering from drug overdose
For more, see https://mjcl.gov.mt/en/justice/Pages/Drug-
Dependence Act.aspx 
Europe responds to health concerns posed by new 
psychoactive substances 
Europe has responded to rising concerns over the use of 
two new drugs by subjecting them to control measures and 
criminal penalties throughout the Union. The implementing 
decision of the Council of the EU (1) was adopted on 8 
October, in the final stage of the three-step legal procedure 
designed to respond to potentially threatening new 
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psychoactive substances (NPS) available on the market 
(2). The two new substances — 4,4’-DMAR (a derivative of 
aminorex with psychostimulant properties) and MT-45 (a 
synthetic opioid investigated in the 1970s for its analgesic 
properties) — have been raising health concerns in Europe 
after harmful effects related to them were reported by 
the Member States through the EU Early Warning System 
(EWS)(3). On 18 November, an extended EMCDDA 
Scientific Committee will meet in Lisbon to undertake the 
risk assessment of a new psychoactive cathinone currently 
detected in over 100 serious adverse events in Europe. 
The substance in question, the stimulant drug α-PVP, is 
the third cathinone to be risk assessed by the agency 
(4). The EMCDDA has also issued early-warning alerts on 
acetylfentanyl, a new potent synthetic opioid with analgesic 
properties, after it was linked to serious harms in the EU. 
Concern over this fentanyl has led the EWS to launch a 
data-collection exercise on this substance. This will lead to 
the preparation of an EMCDDA–Europol Joint report, due in 
December 2015 (5). 
(1)   Council implementing decision (2015/1873) published 
in the Official Journal of the European Union on 
20.10.2015. For more, see news release No 9/2015 at 
www.emcdda.europa.eu/news/2015/9/44-dmar-and-
mt-45 
(2)  Council Decision 2005/387/JHA. For more, see www.
emcdda.europa.eu/activities/action-onnew-drugs 
(3)   Risk assessment reports on the two substances are 
available at www.emcdda.europa.eu/publications/risk-
assessments 
(4)   Joint report available at www.emcdda.europa.eu/
publications/joint-reports/alpha-pvpUpcoming 
risk assessment report at www.emcdda.europa.eu/
publications/risk-assessments 
(5)  Upcoming Joint report at www.emcdda.europa.eu/
publications/joint-reports 
Minimum quality standards in drug demand reduction 
The EU Council of Ministers (General Affairs Council) 
adopted on 14 September ‘Minimum quality standards in 
drug demand reduction in the EU’. This innovative initiative 
lists 16 standards which represent a minimum quality 
benchmark for interventions in: drug use prevention; risk 
and harm reduction; treatment; social integration and 
rehabilitation. The standards are the result of work carried 
out under three consecutive EU presidencies (Greece, Italy, 
Latvia) between January 2014 and June 2015. They were 
drawn up in the context of Action 9 of the EU action plan on 
drugs (2013–16), which calls on the Council, Commission, 
Member States and the EMCDDA ‘to agree and commence 
implementation of EU minimum quality standards’ in 
demand reduction. Although non-binding for national 
governments, these standards represent solid political will 
in the EU to address drug demand reduction through an 
evidence-based perspective. The EMCDDA is invited in the 
document ‘to continue gathering evidence on effective 
interventions and services in drug demand reduction and 
provide Member States with technical support and expertise 
in the implementation of these standards’. It is disseminating 
the standards via its Best Practice portal. The newly adopted 
standards represent a major development in drug policy 
formulation at EU level, bridging expert knowledge and 
political decision-making across 28 countries. 
For more, see www.emcdda.europa.eu/news/2015/ 
eu-minimum- 
Recent publications
The following abstracts are cited from recently published 
journal articles relating to the drugs situation in Ireland.
The challenge of opioid-induced hyperalgeisa
Calami A and Dowdall D (2015) Forum 32 (11): 39–42
http://www.drugsandalcohol.ie/24915/ 
Long-term exposure to opiates or synthetic opioids has 
been shown to sensitise subjects to painful stimuli. This is 
of significance in the areas of chronic pain management (as 
patients receiving opioid analgesia can actually become more 
sensitive to pain) and in managing acute and chronic pain 
in people on the methadone replacement programme for 
addiction to opiates.
‘Codeine is my companion’: misuse and dependence on 
codeine containing medicines in Ireland
Van Hout MC, Horan A, Santlal K, Rich E and Bergin, M (2015) 
Irish Journal of Psychological Medicine Early online 
http://www.drugsandalcohol.ie/24912/ 
Global concern around over-the-counter availability of 
codeine-containing products and risk of misuse, dependence 
and related harms are evident. A phenomenological study 
of lived experiences of codeine misuse and dependence was 
undertaken in Ireland, following the Pharmaceutical Society 
of Ireland’s 2010 guidelines for restricted supply of non-
prescription codeine containing products.
In-depth interviews were conducted with a purposive sample 
of adult codeine misusers and dependents (n=21), both 
actively using, in treatment and in recovery. The narratives 
were analysed using the Empirical Phenomenological 
Psychological five-step method (Karlsson, 1995). A total of 10 
themes with 82 categories were identified. Two concepts at 
a higher level of abstraction above the theme-level emerged 
during the final stage of analysis. The concepts identified 
were ‘emotional pain and user self-legitimization of use’ and 
‘entrapment into habit-forming and invisible dependent use’. 
These concepts were reported in different ways by a majority 
of participants.
Findings are presented under the following themes: (1) profile 
and product preferences; (2) awareness of habit forming use 
and harm; (3) negotiating pharmacy sales; (4) alternative 
sourcing routes; (5) the codeine feeling; (6) the daily routine; 
(7) acute and chronic side effects; (8) social isolation; (9) 
withdrawal and dependence; and (10) help-seeking and 
treatment experiences.
There is a public health and regulatory imperative to develop 
proactive responses tackling public availability of codeine-
From Drugnet Europe (continued)
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containing medicines, risk minimisation in consumer self-
treatment for pain, enhanced patient awareness of potential 
for habit forming use and its consequences, and continued 
health professional pharmacovigilence.
Development and process evaluation of an educational 
intervention for overdose prevention and naloxone 
distribution by general practice trainees 
Klimas J, Egan M, Tobin H, Coleman N and Bury G (2015) 
BMC Medical Education 15 (206)
http://www.drugsandalcohol.ie/24856/
Overdose is the most common cause of fatalities among opioid 
users. Naloxone is a life-saving medication for reversing opioid 
overdose. In Ireland, it is currently available to ambulance and 
emergency care services, but General Practitioners (GP) are 
in regular contact with opioid users and their families. This 
positions them to provide naloxone themselves or to instruct 
patients how to use it. The new Clinical Practice Guidelines 
of the Pre-hospital Emergency Care Council of Ireland allows 
trained bystanders to administer intranasal naloxone. We 
describe the development and process evaluation of an 
educational intervention, designed to help GP trainees identify 
and manage opioid overdose with intranasal naloxone.
Participants (N=23) from one postgraduate training scheme 
in Ireland participated in a one-hour training session. The 
repeated-measures design, using the validated Opioid 
Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales, 
examined changes immediately after training. Acceptability 
and satisfaction with training were measured with a self-
administered questionnaire.
Knowledge of the risks of overdose and appropriate actions 
to be taken increased significantly post-training [OOKS mean 
difference, 3.52 (standard deviation 4.45); P < 0.001]; attitudes 
improved too [OOAS mean difference, 11.13 (SD 6.38); 
P < 0.001]. The most and least useful delivery methods were 
simulation and video respectively.
Appropriate training is a key requirement for the distribution of 
naloxone through general practice. In future studies,  
the knowledge from this pilot will be used to inform a train-
the-trainer model, whereby healthcare professionals and other 
front-line service providers will be trained to instruct opioid 
users and their families in overdose prevention and naloxone 
use.
Effectiveness of a multifaceted intervention for potentially 
inappropriate prescribing in older patients in primary care: 
A cluster-randomized controlled trial (OPTI-SCRIPT study) 
Clyne B, Smith SM, Hughes CM, Boland F, Bradley M, Cooper 
JA and Fahey T (2015) Annals of Family Medicine 18 (6): 
545–553 
http://www.drugsandalcohol.ie/24781/
Potentially inappropriate prescribing (PIP) is common  
in older people and can result in increased morbidity, adverse 
drug events, and hospitalizations. The OPTI-SCRIPT study 
(Optimizing Prescribing for Older People in Primary Care, a 
cluster-randomized controlled trial) tested the effectiveness of 
a multifaceted intervention for reducing PIP in primary care. 
We conducted a cluster-randomized controlled trial among 
21 general practitioner practices and 196 patients with PIP. 
Intervention participants received a complex, multifaceted 
intervention incorporating academic detailing; review 
of medicines with web-based pharmaceutical treatment 
algorithms that provide recommended alternative-treatment 
options; and tailored patient information leaflets. Control 
practices delivered usual care and received simple, patient-
level PIP feedback. Primary outcomes were the proportion 
of patients with PIP and the mean number of potentially 
inappropriate prescriptions. We performed intention-to-treat 
analysis using random-effects regression. 
All 21 practices and 190 patients were followed. At 
intervention completion, patients in the intervention group 
had significantly lower odds of having PIP than patients in 
the control group. The mean number of PIP drugs in the 
intervention group was 0.70, compared with 1.18 in the 
control group (P = .02). The intervention group was almost 
one-third less likely than the control group to have PIP drugs 
at intervention completion, but this difference was not 
significant. The intervention was effective in reducing proton 
pump inhibitor prescribing. 
The OPTI-SCRIPT intervention incorporating academic 
detailing with a pharmacist, and a review of medicines with 
web-based pharmaceutical treatment algorithms, was effective 
in reducing PIP, particularly in modifying prescribing of proton 
pump inhibitors, the most commonly occurring PIP drugs 
nationally.
Clustering of sex and substance use behaviors in 
adolescence
McAloney K (2015) Substance Use & Misuse Early online
http://www.drugsandalcohol.ie/24644/
Adolescents often experiment with substance use and sexual 
activity, which can impact upon their health and well-being, 
and establish harmful patterns of behavior which continue into 
adulthood. While substance use and participation in sexual 
behaviors often co-occur, few studies have examined whether 
these behaviors cluster in adolescence.
Alcohol consumption was the most prevalent risk behavior 
(75%), followed by cigarette smoking, sexual intercourse, 
illicit substance use, and solvent use the least prevalent. Over 
40% of young people participated in multiple risk behaviors 
(2 or more). Several behavior combinations were statistically 
clustered, for most the reported prevalence was lower than 
expected, however, participation in all five risk behaviors 
occurred at a much higher rate than expected, particularly for 
male youth.
While experimentation with risky behaviors is often considered 
developmentally appropriate in adolescence it is important to 
understand how young people experience these behaviors, 
and the potential for multiple risk exposures as a result of 
participation in substance use and sexual behaviors. These 
findings highlight the clustering of substance use and 
sexual behaviors, and indicate variations in vulnerability to 
participation in multiple risk behaviors by gender.
Socioeconomic inequalities in the impact of tobacco 
control policies on adolescent smoking. A multilevel study 
in 29 European countries
Pförtner T-K, Hublet A, Schnohr CW, Rathmann K, Moor I, de 
Looze M, Baška T, Molcho M, Kannas L, Kunst AE and Richter 
M (2015) Addictive Behaviors 53: 58–66
http://www.drugsandalcohol.ie/24618/
Data were used from the Health Behaviour in School-aged 
Children (HBSC) study conducted in 2005/2006 comprising 
50,338 adolescents aged 15 years from 29 European countries. 
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Multilevel logistic regression analyses were conducted to 
assess the association of weekly smoking with components of 
the Tobacco Control Scale (TCS), and to assess whether this 
association varied according to family affluence (FAS). Analyses 
were carried out per gender and adjusted for national wealth 
and general smoking rate.
Results indicated that most tobacco control policies are not 
clearly related to adolescent weekly smoking across European 
countries. Only tobacco price seemed to be adequate 
decreasing smoking prevalence among boys, irrespective of 
their socioeconomic status.
Personality and substance use: psychometric evaluation 
and validation of the Substance Use Risk Profile Scale 
(SURPS) in English, Irish, French, and German adolescents
Jurk S et al. (2015) Alcoholism Clinical and Experimental 
Research, Early online 
http://www.drugsandalcohol.ie/24665/
The aim of the present longitudinal study was the psychometric 
evaluation of the Substance Use Risk Profile Scale (SURPS).
We analyzed data from N = 2,022 adolescents aged 13 to 15 
at baseline assessment and 2 years later (mean interval 2.11 
years). Missing data at follow-up were imputed (N = 522). 
Psychometric properties of the SURPS were analyzed using 
confirmatory factor analysis. We examined structural as well as 
convergent validity with other personality measurements and 
drinking motives, and predictive validity for substance use at 
follow-up.
The hypothesized 4-factorial structure (i.e., anxiety sensitivity, 
hopelessness, impulsivity [IMP], and sensation seeking [SS]) 
based on all 23 items resulted in acceptable fit to empirical 
data, acceptable internal consistencies, low to moderate test-
retest reliability coefficients, as well as evidence for factorial 
and convergent validity. The proposed factor structure was 
stable for both males and females and, to lesser degree, across 
languages. However, only the SS and the IMP subscales of the 
SURPS predicted substance use outcomes at 16 years of age.
The SURPS is unique in its specific assessment of traits related 
to substance use disorders as well as the resulting shortened 
administration time. Test-retest reliability was low to moderate 
and comparable to other personality scales. However, its 
relation to future substance use was limited to the SS and 
IMP subscales, which may be due to the relatively low-risk 
substance use pattern in the present sample.
Vulnerable families and drug use: examining care 
admissions of children of parents attending an Irish drug 
treatment facility 
McGivern A and McDonnell C (2015) The Irish Social Worker 
(Spring): 17–23 
http://www.drugsandalcohol.ie/24712/
Harmful substance use has a detrimental effect on parenting 
and child welfare agencies consistently confirm such usage 
as a primary factor in initial referral. This article examines the 
circumstances of child admissions to care over a nine year 
period, from families where one or both parents attend a 
centralized drug treatment services. A recurrent theme during 
the study period was low rates of family reunifications within a 
twelve month period. Furthermore, we identified factors which 
in the view of natural parents and the service social work 
team have contributed significantly when families have been 
reunited.
Low resolution and high resolution MS for studies on 
the metabolism and toxicological detection of the new 
psychoactive substance methoxypiperamide (MeOP)
Meyer MR, Holderbaum A, Kavanagh P and Maurer HH (2015) 
Journal of Mass Spectrometry 50 (10): 1163–74
http://www.drugsandalcohol.ie/24617/
In 2013, the new psychoactive substance methoxypiperamide 
(MeOP) was first reported to the European Monitoring 
Centre for Drugs and Drug Addiction. Its structural similarity 
to already controlled piperazine designer drugs might have 
contributed to the decision to offer MeOP for online purchase. 
The aims of this work were to identify the phase I/II 
metabolites of MeOP in rat urine and the human cytochrome 
P450 (CYP) isoenzymes responsible for the initial metabolic 
steps. Finally, the detectability of MeOP in rat urine by gas 
chromatography-mass spectrometry (GC-MS) and liquid 
chromatography coupled with multistage mass spectrometry 
(LC-MS(n) ) standard urine screening approaches (SUSAs) was 
evaluated. After sample preparation by cleavage of conjugates 
followed by extraction for elucidating phase I metabolites, 
the analytes were separated and identified by GC-MS as 
well as liquid chromatography-high resolution-tandem mass 
spectrometry (LC-HR-MS/MS). For detection of phase II 
metabolites, the analytes were separated and identified after 
urine precipitation followed by LC-HR-MS/MS. The following 
metabolic steps could be postulated: hydrolysis of the amide, 
N-oxide formation, N- and/or O-demethylation, oxidation 
of the piperazine ring to the corresponding keto-piperazine, 
piperazine ring opening followed by oxidation of a methylene 
group to the corresponding imide, and hydroxylation of the 
phenyl group. Furthermore, N-acetylation, glucuronidation 
and sulfation were observed. 
Using human CYPs, CYP1A2, CYP2C19, CYP2D6, and/
or CYP3A4 were found to catalyze N-oxide formation and 
N-, O-demethylation and/or oxidation. Mostly MeOP and 
N-oxide-MeOP but to a minor degree also other metabolites 
could be detected in the GC-MS and LC-MS(n) SUSAs. 
Copyright © 2015 John Wiley & Sons, Ltd.
Examining the use of community service orders as 
alternatives to short prison sentences in Ireland 
O’Hara K and Rogan M (2015) Irish Probation Journal,  
12 http://www.drugsandalcohol.ie/24883/
Ireland’s highly discretionary sentencing system provides 
a rare opportunity to study the behaviour of judges when 
relatively free of externally imposed constraints. While this is 
so, few studies have investigated sentencing trends. In 2011, 
Ireland introduced the Criminal Justice (Community Service) 
(Amendment) Act 2011 requiring courts to consider imposing 
Community Service Orders (CSOs) in cases where sentences 
of less than twelve months are deemed appropriate. A CSO 
is a direct prison alternative requiring offenders to complete 
between forty and 240 hours unpaid community work in 
lieu of a prison term. In order to complete comparative 
analysis, administrative data pertaining to all cases sentenced 
to a short term of imprisonment or CSO between 2011 and 
2012 were linked and analysed. Analysis of offence groups 
showed that more cases convicted of drug, public order, 
and robbery or related offences received Community Service 
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than was expected; however effect sizes were small. Findings 
showed the average number of Community Service hours 
equivalent to one month of imprisonment differed by offence 
type and District Court jurisdiction. As the first of its kind in 
Ireland, this study provides a rare glimpse of the use of these 
two alternative criminal justice sanctions. Findings and their 
implications are discussed.
Coolmine Therapeutic Community, Dublin: a forty-year 
history of Ireland’s first voluntary drug treatment service
Butler S (2015) Addiction Early online 
http://www.drugsandalcohol.ie/24509/
To document the evolution over forty years (1973–2013) of 
Coolmine Therapeutic Community (Ireland’s first voluntary 
drug treatment service) against a background of broader drug 
policy developments in the Republic of Ireland and elsewhere 
during this period, data were gathered by means of archival 
research within Coolmine, complemented by semi-structured 
interviews with former clients, current and former Coolmine 
management and staff, and representatives of outsider 
stakeholder interests.
Coolmines’s history has three phases: (1) an early and 
uncontentious phase in which external authorities provided 
financial support for Coolmine without questioning its work 
practices or outcomes; (2) a middle, controversial phase in 
which Coolmine struggled for survival in an external policy 
environment now dominated by harm reduction strategies; 
and (3) a final phase in which, through the use of conventional 
corporate governance, Coolmine management sought to 
repair its damaged reputation by introducing evidence-based 
clinical practices.
Coolmine Therapeutic Community was established when 
drug treatment services in Ireland were in their infancy, and 
its changing fortunes over subsequent decades reflected 
changing perceptions of what constitutes appropriate 
addiction treatment – and in particular the role to be played 
by former addicts within addiction treatment systems – as well 
as changing perceptions of funding relationships between 
statutory authorities and voluntary providers of health and 
social services.
The drug situation in Europe: an overview of data available 
on illicit drugs and new psychoactive substances from 
European monitoring in 2015
Mounteney J, Griffiths P, Sedefov R, Noor A, Vicente J and 
Simon R (2015) Addiction Early online 
http://www.drugsandalcohol.ie/24570/
A central task for the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA) is to produce an annual 
report of the latest data available on drug demand and drug 
supply in Europe. This paper is intended to facilitate a better 
understanding of, and easier access to, the main quantitative 
European level data sets available in 2015.
The European reporting system formally covers all 28 
European Union (EU) Member States, Norway and Turkey and 
incorporates multiple indicators alongside an early warning 
system (EWS) on uncontrolled new psychoactive substances 
(NPS). While epidemiological information is based largely on 
registries, surveys and other routine data reported annually, 
the EWS collects case-based data on an ongoing basis. The 
2015 reporting exercise is centred primarily on a set of 
standardized reporting tools.
The most recent data provided by European countries 
are presented, including data on drug use, drug-related 
morbidity and mortality, treatment demand, drug markets 
and new psychoactive substances, with data tables provided 
and methodological information. A number of key results 
are highlighted for illustrative purposes. Drug prevalence 
estimates from national surveys since 2012 (last year 
prevalence of use among the 15-34 age band) range from 
0.4% in Turkey to 22.1% in France for cannabis, from 0.2% 
in Greece and Romania to 4.2% in the United Kingdom for 
cocaine, from 0.1% in Italy and Turkey to 3% in the Czech 
Republic and the United Kingdom for ecstasy, and from 0.1% 
or less in Romania, Italy and Portugal to 2.5% in Estonia 
for amphetamine. Declining trends in new HIV detections 
among people who inject drugs are illustrated, in addition to 
presentation of a breakdown of NPS reported to the EU early 
warning system, which have risen exponentially from fewer 
than 20 a year between 2005 and 2008, to 101 reported in 
2014.
Structured information is now available on patterns and 
trends in drug consumption in Europe, which permits 
triangulation of data from different sources and consideration 
of methodological limitations. Opioid drugs continue to 
place a burden on the drug treatment system, although both 
new heroin entrants and injecting show declines. More than 
450 new psychoactive substances are now monitored by 
the European early warning system with 31 new synthetic 
cathinones and 30 new synthetic cannabinoid receptor 
agonists notified in 2014.
Alcohol consumption and cardiovascular disease, cancer, 
injury, admission to hospital, and mortality: a prospective 
cohort study 
Smyth A et al. (2015) Lancet 
http://www.drugsandalcohol.ie/24524/ 
Alcohol consumption is proposed to be the third most 
important modifiable risk factor for death and disability. 
However, alcohol consumption has been associated with both 
benefits and harms, and previous studies were mostly done in 
high-income countries. We investigated associations between 
alcohol consumption and outcomes in a prospective cohort of 
countries at different economic levels in five continents.
We included information from 12 countries participating in 
the Prospective Urban Rural Epidemiological (PURE) study, a 
prospective cohort study of individuals aged 35-70 years. We 
used Cox proportional hazards regression to study associations 
with mortality (n=2723), cardiovascular disease (n=2742), 
myocardial infarction (n=979), stroke (n=817), alcohol-
related cancer (n=764), injury (n=824), admission to hospital 
(n=8786), and for a composite of these outcomes (n=11 963).
We included 114 970 adults, of whom 12 904 (11%) were 
from high-income countries (HICs), 24 408 (21%) were 
from upper-middle-income countries (UMICs), 48 845 
(43%) were from lower-middle-income countries (LMICs), 
and 28 813 (25%) were from low-income countries (LICs). 
Median follow-up was 4·3 years (IQR 3·0-6·0). Current 
drinking was reported by 36 030 (31%) individuals, and was 
associated with reduced myocardial infarction (hazard ratio 
[HR] 0·76 [95% CI 0·63-0·93]), but increased alcohol-related 
cancers (HR 1·51 [1·22-1·89]) and injury (HR 1·29 [1·04-
1·61]). High intake was associated with increased mortality 
(HR 1·31 [1·04-1·66]). Compared with never drinkers, we 
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Upcoming events
March 2016
22–23 March 2016
Marijuana and cannabinoids: a neuroscience  
research summit
Venue: Natcher Conference Center, Building 45, NIH 
campus, Bethesda, Maryland, USA
Organised by: National Institutes of Health (NIH)
Further information: http://apps1.seiservices.com/nih/
mj/2016/ 
The conference will focus on the neurological and 
psychiatric effects of marijuana, other cannabinoids, and the 
endocannabinoid system. Both the adverse and the potential 
therapeutic effects of the cannabinoid system will be 
discussed. The goal to ensure evidence-based information is 
available to inform practice and policy, particularly important 
at this time given the rapidly shifting landscape regarding 
the recreational and medicinal use of marijuana. 
April 2016
19–21 April 2016
United Nations General Assembly Special Session on the 
World Drug Problem (UNGASS 2016)
Venue: UN Headquarters, New York, USA
Organised by: Department of General Assembly and 
Conference Management 
Further information: http://www.unodc.org/ungass2016/
en/about.html 
The Special Session will be an important milestone in achieving 
the goals set in the policy document of 2009 Political 
Declaration and Plan of Action on International Cooperation 
towards an Integrated and Balanced Strategy to Counter the 
World Drug Problem, which defined action to be taken by 
member states as well as goals to be achieved by 2019. 
Member states, UN entities and specialised agencies, 
intergovernmental organisations, as well as NGOs  
accredited to participate in the Special Session, are being 
given the opportunity to hold side events. Starting on 18 
April and running concurrently with the Special Session, 
these side events will be on topics thematically relevant to 
the UNGASS.
May 2016
16–18 May 2016
10th Annual Conference of the International Society for 
the Study of Drug Policy (ISSDP) 
Venue: Q Station, North Head Scenic Drive, Manly NSW 
2095, Australia
Organised by: Drug Policy Modelling Program (DPMP), 
National Drug and Alcohol Research Centre (NDARC), 
UNSW Australia
Further information: http://www.issdp2016.com/
 
The aims of the ISSDP conference are to:
 ■ present original scientific research on drug policy;
 ■  create opportunities for vigorous discussion and debate 
about findings and methods;
 ■  provide an environment conducive for networking and 
the establishment of new collaborations;
 ■  provide a stimulus for delegates to publish their work in 
journals; and
 ■  inform policy makers about the latest scientific evidence 
underpinning drug policy.
In showcasing Australia, New Zealand and our region, the 
conference themes include:
 ■  Harm reduction: old, new and emerging forms of harm 
reduction
 ■  Drugs policy and its intersection with human rights and 
development
 ■ Indigenous peoples and illicit drug policy
 ■  Drug markets and policy responses in Australia, New 
Zealand and Asia Pacific
 ■  Drug user groups and drug policy: the role of consumers 
and other stakeholders
In addition to these themes, we are also aware of the 
international drug policy stage, with the UN General 
Assembly Special Session (UNGASS) on drugs in April 2016. 
The conference will include analysis of international drug 
policy reforms, the international drug control system and 
analysis of the event itself.
identified significantly reduced hazards for the composite 
outcome for current drinkers in HICs and UMICs (HR 0·84 
[0·77-0·92]), but not in LMICs and LICs, for which we 
identified no reductions in this outcome (HR 1·07 [0·95-
1·21]; pinteraction<0·0001).
Current alcohol consumption had differing associations 
by clinical outcome, and differing associations by income 
region. However, we identified sufficient commonalities to 
support global health strategies and national initiatives to 
reduce harmful alcohol use.
Recent publications (continued)
Johnny Connolly
Dr Johnny Connolly has left the HRB after 13 years 
working on drug-related crime and markets indicators for 
the Irish EMCCDA focal point. 
During his time with the HRB Johnny completed a number 
of pieces of research.  His most notable achievement was 
the first ever study of illicit drug markets in Ireland, which 
was published in 2014.
Johnny will shortly leave Dublin to live in the 
Cloughjordan ecovillage in North Tipperary and we wish 
him and his family well in this big move.
